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Abstract
THE CHARACTERIZATION OF Pb2+ TOXICITY IN RAT NEURAL DEVELOPMENT: AN
ASSESSMENT OF Pb2+ EFFECTS ON THE GABA SHIFT IN NEURAL NETWORKS AND
IMPLICATIONS FOR LEARNING AND MEMORY DISRUPTION
By

LORENZ SIMON NEUWIRTH

Adviser: Professor Abdeslem El Idrissi, Ph.D.
The toxic effects of Pb2+ on the developing rat nervous system has been investigated to assess
early developmental GABAergic disruption and its implications with altering inhibitory learning
and memory. This goal was achieved using a multi-systems approach: blood lead levels (clinical
physiology), qRT-PCR (molecular genetics), brain and primary neuronal culture immunology
(immunohistochemical

and

cellular

approaches),

physiological

cellular

components

(synaptosomes and protein expression) and finally through learning and memory assessment
with GABA mimetic drug manipulations in the intact animal (behavioral pharmacology). The
influence of a 956ppm Pb2+ gestational diet (i.e. from birth to sacrifice) resulted in pup mean
blood lead levels (BLLs measured in μg/dL) (Range

28-47)

and Dams (Range 33-51)

respectively. In contrast, control pups and dams were Pb2+ negative. These ages were selected to
determine neurodevelopmental trajectories of the GABA-shift from excitation-to-inhibition
postnatally in our model. qRT-PCR studies evinced a delay in mRNA expression regulating
GAD 80, 65, CACAN β3, GABAAR and were differentially regulated cortex and hippocampus as
a function of age in response to Pb2+. Brain slice immunohistochemistry revealed an early shift
of KCC2 expression in both cortex and hippocampus.

Notably, these alterations were

differentially regulated by age, brain region and subcellular circuitry within structures (i.e. DG
vs. CA3). Neuronal cultures revealed that in response to Pb2+ at low micro molar concentrations
iv

induced VSCC-β3 nuclear translocation and GABAAR upregulation. KCC2 expression was
inhibiting in cultures by Pb2+.

Synaptosomal effects of Pb2+ revealed altered glutamate

accumulation and handling with increased spontaneous and decreased evoked release in
significantly modulated by Pb exposure suggesting altered brain synaptogenesis. Pb2+ exposure
resulted in increased binding suggesting post synaptic modification in cortex and hippocampus
increasing brain excitability. Behaviorally, Pb2+ exposure resulted in increased anxiety,
impulsivity, stress, and disrupted learning and memory regulated by inhibitory circuits that were
recovered with taurine, a GABAAR agonist, administration. Specifically, Pb2+ disrupted
contextual and auditory associative learning. Taken together, these results suggest that Pb2+
interferes with early VSCCs and GABAAR synergistic action that establishes GABAergic neural
networks and in turn produces increased brain excitability and over reactivity as a consequence
of reduced inhibition.
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The Characterization of Pb2+ Toxicity in Rat Neural Development:
An Assessment of Pb2+ effects on the GABA shift in neural networks and implications for
learning and memory disruption.

1.0 - Background and Significance:

1.1-Blood lead levels and their relation to neurotoxicity
Lead (Pb2+) is an antiquated poison with resourceful malleable metallic properties, yet its
toxicity has been reported to result in various neurological disruptions, with particular sensitivity
in the cortex, hippocampus, and cerebellum (Finkelstein et al., 1998). Goldstein (1992) first
hypothesized that “Pb2+ may negatively affect early synaptogenesis disrupting early brain
plasticity during critical stages of development.” Children are most vulnerable to Pb2+
neurotoxicity due to an increase in absorbed lead via respiration and/or ingestion. In contrast,
dermal absorption is rare and toxicity benign. Sixty percent of absorbed Pb2+ is cleared in urine
via filtration in the kidneys (Chisolm et al., 1991). Absorbed Pb2+ enters the blood stream, 95%
is transported by erythrocytes and distributed throughout the bodily organs; whereas 5% remains
in the plasma (Lidsky and Schneider, 2003). The half-life of Pb2+ in blood is ~ 35 days, ~ 2
years in brain, and dependent upon the size and amount of calcium (Ca2+) accumulation in bone,
it can remain circulating for decades (Lidsky and Schneider, 2003). In addition, Pb2+ is
transported into the brain by calcium-adenosine triphosphate enzyme pumps (Ca2+-ATPase)
located on the endothelial cells that comprise the blood brain barrier (Kerper and Hinkle, 1997a).
This route of brain lead deposition suggests an early susceptibility for children to be at increased
risk for neurotoxicity during critical stages of brain development altering growth, myelination,
synaptogenesis, and inhibitory regulation.
Chelation therapy is an invaluable preventative measure for lowering Pb2+ toxicity.
However, it fails to address the neurological sequelae associated with childhood Pb2+ poisoning
(Toscano and Guilarte, 2001) due to continuous need for invasive procedures that children find
aversive. Moreover, it does not prevent mobilization of skeletal Pb2+ stores that can persist years
following exposure (e.g. the femur has a duration of Pb2+ mobilization from bone over a course
of ~30 years post initial exposure) (Gulson et al., 2003). Moreover, Pb2+ exposed mothers
1

bearing children can produce increased toxicity to their children by Pb2+ ability to enter the
placenta (Hu and Hernandez-Avila, 2002). Children chronically exposed to Pb2+ endure brain
damage as evidenced by reductions of 0-5 intelligent quotient (IQ) scaled points for every
increase in 10µg/dL of Pb2+ concentration in blood (Lidsky and Schneider, 2006; Bellinger,
1995). The inverse relationship between high blood lead levels (BLLs) and decreased IQ points
is well documented. Emergent chelation therapy is advised when BLLs reach and/or exceed 39
µg/dL; which may have already caused irreparable IQ deficits ranging from 15-20 points (Lidsky
and Schneider, 2006; Bellinger, 1995) depending on the initial Pb2+ concentration and duration of
exposure. Moreover, reduced IQ scores induced by Pb2+ poisoning are correlated with learning
disabilities, hyperactivity, aggression, antisocial behaviors, attention deficit disorders, autism,
hearing and speech impediments, and seizure disorders (Bellinger, 1996; Lidsky and Schneider,
2006; Kovatsi et al, 2010; Abayzan et al, 2013). Notably, the higher the Pb2+ burden the more
observable symptomatic conditions were observed.
The body of literature on Pb2+ toxicity research, in both clinical and animal models,
historically focused on alterations in adult cognitive impairment and behavioral sequelae at high
BLLs. Silbergeld (1992) initially proposed that although Pb2+ poisoning causes insults to neural
development, biological compensation ensues through as yet described mechanisms, masking
observable cognitive and behavioral symptoms throughout youth and adolescence. In addition,
these symptoms are revealed later in life by inevitable age-dependent neurodegeneration
(Figure 1.). However, given the advancement of technologies and more sensitive measurements
for scrutinizing behavioral methods animals will low BLL's can evince behavioral differences
indicating that Siblergeld's (1992) model is deemed inaccurate and unspecific when explaining
all possibilities relating to Pb2+ effects on early brain development. Moreover, early brain
developmental overgrowth may contribute to masking effects of observable symptoms prior to
synaptogenic events, equivocally substantial damage to early brain development will not be
masked simply to brain overgrowth as they compromised functional brain mechanisms
contributing to behavioral outcomes will produce deficits in action.
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Figure 1. Suggested developmental timeline for unmasking Pb2+ symptoms as a function of age
dependent biological compensation and neurodegeneration prior to the advancement of
technology and more sensitive research studies [Adapted from Silbergeld (1992)].
Previously, clinical studies in children through employing neuropsychological testing
(Lidsky and Schneider, 2006) and perturbations in animal models of postnatal development
correlated Pb2+-induced impairments in sensory cortex (Wilson et al., 2000) and hippocampal
learning and memory (Gilbert et al., 1996; Murphy and Regan, 1998). These animal models are
used as valid model systems to investigate the underlying neurobiological consequences of Pb2+
and their relationship to IQ. Neurocognitive behaviors that regulate attention, visual-motor
reasoning skills, social skills, mathematics, and reading skills are reported to be abnormal in
children with BLLs lower than 10µg/dL (Canfield et al., 2003; Lanphear et al., 2000; Lanphear
et al., 2005; Wasserman et al., 1997). Nevin (2007) used correlational models between
individual’s preschool BLLs with concurrent rates of homicides, crimes, and tetra-ethyl lead
gasoline exposure predicting that children chronically exposed to Pb2+ would have reduced IQ,
fail out of school, become delinquent, increased risk for imprisonment and ultimately result in an
increased government financial burden due to leaded gasoline manufacturing.
Estimates by the United States Environmental Protection Agency (USEPA) have
calculated that a decline in a single point of a child's IQ results in an added financial burden of
$8,346 per poisoned child annually (USEPA, 1997). Summative small IQ deficits can shift an
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entire population distribution leftward further increasing government financial aid of a given
country (Godwin, 2009) (Figure 2.).

Figure 2. Simulation of governmental financial burden as a function of Pb2+ induced IQ
reductions in children [Adapted from Godwin, 2009].
In the United States from 1976-1980 it was estimated that 88% of children between 1-5
years old had elevated BLLs >10µg/dL (Meyer et al., 2003). By 1997, the percentage of Pb2+exposed children dropped from 88% to 5% (Meyer et al., 2003), and 3% of Pb2+-exposed
children are concentrated in low income and socially disadvantaged urban areas (Lidsky and
Schneider, 2003). Globally, the percent of children requiring similar supports is striking but must
be examined with caution (Toscano and Guilarte, 2005) (See Figure 3.).
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Figure 3. Comparison of elevated BLL prevalence between the US and other countries
[Adapted from Toscano and Guilarte, (2005)].
Interpretation of data from Pb2+ research during the last ~60 years is complicated by the
use of varied clinical studies with high BLLs that are rare today. The Center for Disease Control
and Prevention (CDC) has recommended 10µg/dL (i.e. 0.48µmol/L) as the “level of concern”
actionable intervention criteria for pediatric screenings in children (CDC, 1991). Using this
criteria, clinical studies reveal brain alterations at levels below 10µg/dL, suggesting even this
supposed minimum concentration is not safe (Koller et al., 2004). To further elucidate the
molecular mechanisms underlying cognitive disruption at BLLs below 10µg/dL, various animal
models have been used (For Review see Silbergeld and Goldberg, 1980; Jason and Kellog,
1980). In response to convincing clinical and animal studies of low BLL’s inducing neurological
impairment, the CDC’s Advisory Committee on Childhood Lead Poisoning Prevention (2012)
redacted the term “level of concern”, and are now reliant on a “reference level” of 5µg/dL (i.e.
0.24 µmol/L) based on 97.5% of the US population of lead poisoned children in this range.
Inconsistencies from animal studies makes it difficult to establish the effects of Pb2+ on
parameters used in human subjects. Among the inconsistencies are: a) age (Jet et al., 1997;
Singh and Jiang, 1997; Hussain et al., 2000; Zaiser and Miletic, 2000), b) altered Pb2+ kinetics in
long term potentiation (LTP) [a model of hippocampal learning and memory consolidation]
(Gilbert et al., 1996; Gilbert et al., 1999; Hussain et al., 2000, Liu et al., 2000; Zaiser and
Miletic, 2000), and c) observable behavior learning deficits (Regan and Keegan, 1990; RashidyPour et al., 1995; Bourjeily and Suszkiw, 1997; Jett et al., 1997). Moreover, inconsistent dosedependent concentrations of Pb2+ have resulted in unrefined animal models (Spence et al., 1985;
Minnema and Michaelson, 1986; Strużyñska and Rafalowska, 1994; Gilbert et al., 1999). Effects
of Pb2+ on animal tissues studied in vitro are also conflicting due to both poor detection methods
in overcoming Pb2+ precipitation from test solutions (Drew et al., 1989) and gender differences
between studies (Vahter et al., 2007). Vahter et al. (2007) reported that young males are more
susceptible for Pb2+ neurotoxicity in early life, whereas young females are more susceptible to
immunotoxic effects of Pb2+. This suggests sex differences being differentially affected in
response to Pb2+. These findings elucidate that Pb2+ may disrupt specific pathways in the
endocrine system with influence towards emotional learning, anxiety, and fear conditioning.
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1.2-Pb2+ effects on Central Nervous Tissues
To compensate for species differences in extrapolating lead toxicity effects that would
most appropriately generalize to human clinical conditions. In vivo studies are advantageous as it
permits researchers to identify the effects of Pb2+ in a live behaving organism with assessment of
the Pb2+-induced underlying biological changes and its interaction with environment. Such an
approach permits the researcher with the ability to discover drug to treat the induced condition
and to subsequently identify the pharmacotherapeutic tolerance of the organism as a bridge to
translational biomedicine. However, in vivo studies are limited in that experimental
manipulations during real-time physiology are less precise than methods employed in vitro. In
vitro methods offer more careful control of manipulating neurochemical and genetic interactions
with the complex environment of a simulated intact organism. Notably, not all results produced
by well controlled in vitro methods are accurately extrapolated back to a behaving organism.
Research shifted to predominantly animal in vitro approaches to isolate central nervous
system (CNS) tissues to investigate direct Pb2+ consequences on neuron populations.
Oligodendrocytes are most vulnerable to Pb2+ exposure (Tang et al., 1996) and their early
progenitors far more susceptible to Pb2+ disruptions than mature oligodendrocytes (Deng et al.,
2001). Suggesting fetal neurons are more vulnerable to Pb2+ toxicity than mature neurons. Pb2+induced delayed myelination, hypomyelination, and demyelination of neurons resulting in
aberrant and/or absent CNS signaling (Coria et al., 1984). Within the first 2-3 years of postnatal
development the brain undergoes massive myelination. Pb2+ insults during this critical stage
generates abnormalities in CNS myelin sheaths (Dabrowska-Brouta et al., 1999) and Schwann
cells in peripheral nervous system (PNS) (Dyck et al., 1977). This malformation of the myelin
sheath drastically affects brain structure and function. A major enzyme critical for myelin
synthesis (2', 3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase) has reduced activity in
response to Pb2+ exposure (Dabrowska-Brouta et al., 2000).
Tiffany-Castiglioni et al., (1989) proposed a 'lead sink' hypothesis suggesting that Pb2+
accumulates in astrocytes within the developing and mature brain, indirectly perturbing neurons.
Astrocytic Pb2+ accumulation is observed in non-mitochondrial sites as a protective mechanism
against cellular respiratory processes and surrounding vulnerable neurons (Lindahl et al., 1999).
Moreover, evidence from tissue cultures indicate that immature astrocytes are more sensitive to
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Pb2+ sequestration, yield higher concentrations and retain these levels far after initial exposure in
contrast to mature astrocytes (Tiffany-Castiglioni et al., 1989; 2001; Lindahl et al., 1999).
Notably, consistent with the 'lead sink' hypothesis, Pb2+-storing astrocytes in early development
may cause age-related leakage, either by increasing local Pb2+ concentrations or inducing focal
Pb2+ lesions contributing to increased intracranial pressure, edema, and decreased brain volume
(Cecil et al., 2008).
Pb2+ has a unique function in neurons given its ability to be substituted for calcium
(Ca2+), producing widespread toxic effects (Bressler and Goldstein, 1999). Studies have
characterized molecular pathways and established clear toxic dose dependent thresholds, in
response to Pb2+ / Ca2+ competition (Kerper and Hinkle, 1997b). Taken together, these reports
suggest that neurons are extremely sensitive to Pb2+ exposure during development, and are more
sensitive to lead than other divalent cations. This is consistent with the suggestion that there is no
safe neurobiological concentration of Pb2+ (Koller et al., 2004).
Pb2+ at nanomolar concentrations competes with intracellular Ca2+ levels, activating
calmodulin and in turn, stimulates protein kinase A (PKA), cyclic adenosine monophosphate
(cAMP), phosphodiesterases, and voltage gated potassium (K+) channels (Bressler et al., 1999).
Moreover, Pb2+ at picomolar concentrations substitutes for Ca2+ and increases calmodulin
activity, whereas at high concentrations reduces calmodulin activity in neurons resulting in
altered intracellular Ca2+ homeostasis (Ferguson et al., 2000; Kern and Audesirk, 2000). PKA
activation stimulates transcription factors that regulate gene expression. Pb2+ may alter gene
expression through PKA downstream of adenynyl cyclase (AC) pathways (whose downstream
modulator is cAMP), quickly inactivating or prolonging activation through phosphodiesterases
altering gene expression.
Moreover, picomolar concentrations of Pb2+ in neurons activates protein kinase C (PKC),
a major cellular regulator for neuronal proliferation and differentiation that is involved in
neuroplasticity via long-term potentiation (LTP) (Bressler and Goldstein, 1991), which is more
sensitive than nanomolar concentrations of Ca2+ that typically activate PKC (Bressler et a.,
1999). Markedly, hippocampal PKC expression has been shown to be reduced at 31.9µg/dL,
consistent with the emergent chelation criteria for intervention at BLLs <39µg/dL (i.e. ~ 1.51.7μM brain tissue concentration), implicating a clear correlation with increased BLLs and
decreases in hipppocampal PKC expression that may result in learning and memory disruption
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(Sun et al., 1999; Mazzonlini et al., 2001; Hussain et al., 2000). Together these reports suggest
Pb2+ competition with Ca2+ mishandling in neonatal and adult brains (Singh and Jiang, 1997;
Silbergeld et al., 1980). However, with increased focus of Pb2+ effects on early CNS
developmental consequences, in vivo and in vitro, the precise molecular mechanisms occurring at
BLLs below 10µg/dL resulting in neurological sequelae during early development remains to be
elucidated.

1.3-L-type VSCCs: Encoding, functioning, and spatial distribution
Ca2+ enters the cell via two distinct routes: the voltage sensitive calcium channels
(VSCCs) or the glutamatergic N-methyl-D-aspartate receptors (NMDARs); which are both
ligand and voltage-sensitive resulting in widespread changes in gene expression through
NMDAR Ca2+ influx. Of the Glutamatergic receptors the NMDAR have higher selective
permeability to Na+ and Ca2+; which produce fast activation and slow inactivation channel
kinetics. The activation of NMDARs require large membrane depolarizations (above -50mV), as
well as, the binding of glutamate and its co-agonist glycine to remove the magnesium (Mg2+) ion
depolarization block which resides in the ion channel pore (Gallin and Greenberg, 1995). Once
Mg2+ is removed, sodium (Na+) and Ca2+ influx increase membrane excitability and Ca2+dependent second messenger signals.
In contrast to NMDARs, VSCCs have selectivity for only Ca2+ ions, but vary in their
distinct functional membrane excitability, which is regulated by the type of VSCC activated and
their subunit configurations. For the purposes of this work we will remain focused on the L-type
VSCC. Ca2+ enters the VSCCs with very high permeability resulting in fast activation and slow
inactivation rates producing very large and precise localization of influx, permitting rapid and
efficient interaction with Ca2+ specific second and third messenger systems.
Calcium channels are assembled through a variety of subunit configurations exceeding 20
different types in the human genome (Herlitze and Mark, 2005). L-Type VSCCs are comprised
of functionally specific subunits α1, β, α2, δ and γ (See Figure 4.).
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Figure 4. The L-Type VSCCs main α1 subunit and its β, δ and γ ancillary subunits. Note that
the β subunit is the only intracellular target of this channel in which nuclear translocation of the
C-terminus has been reported to augment and maintain Ca2+ homeostasis in neurons [Adapted
from Benarroch, (2010)].
From these arrangements, α1 is the main subunit responsible for Ca2+ conductance and
bridges the ancillary subunits together forming the channel pore; whereas the remaining ancillary
subunits (i.e. β, α2, δ and γ) are responsible for intracellular and extracellular transmembrane
VSCC modulation. VSCC subunits encoded by Cav1.1 are expressed in skeletal muscle and
cardiomyocytes (Hase et al., 1994; Mejia-Alvarez et al., 1994; Klugbauer et al., 2002), The
subunits Cav1.4 are expressed in retinal tissues and dorsal root ganglia (Morgans, 2001; Yusaf et
al., 2001). Notably, two particular subunits encoded by Cav1.2 and Cav1.3 mRNA in brain tissue
contributes to α1 subunits L-Type VSCC currents (Snutch et al., 1991: Williams et al., 1992).
Of the many brain regions, L-Type VSCCs in the cortex, hippocampus, and cerebellum
(Snutch et al., 1991; Williams et al., 1992) linking integrative dendritic and somatic signals to
excitation transcription coupling from the membrane to nucleus. An example of this excitation
transcription coupling would be L-Type VSCCs and cyclic AMP response element binding
protein (CREB) phosphorylation regulating mechanisms for learning and memory through the
mitogen activated protein kinase (MAPK) pathway (Atkins et al., 1998, Dolmetsch et al., 2001;
Riberio et al., 2005). Consistent with these findings, spatial distribution analyses have revealed
that L-Type VSCCs are localized to basal dendrites (Westenbroek et al., 1990) with weaker
immunoreactivity in distal arbors (Hell et al., 1993). Notably, gamma-aminobutyric acid
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(GABAergic) mouse cortical neurons were observed to lack such spatial distribution patterns of
Cav1.2 and Cav1.3 α1 subunits and instead both were localized to the proximal dendrites and soma.
This spatial patterning of the precise location of L-Type VSCCs relative to the soma suggests a
close interaction between the L-Type VSCC and GABAergic neurons regulating genes (See
Figure 5.).

Figure 5. The L-Type VSCCs β3 subunit autoregulation of cell excitability in early immature
neurons.
L-Type VSCCs are critical for early immature neurotransmitter release, facilitating
specific developmental events that dictate the temporal and spatial expression patterns of Cav1.2
and Cav1.3 mRNA. This developmental Cav1.2 and Cav1.3 mRNA expression trajectory may be
susceptible for altered expression of the VSCC auxiliary subunits in response to Pb2+.
In studies using regenerated neuromuscular junctions, L-Type VSCC antagonists increase
evoked and inhibit spontaneous neurotransmitter release, signifying early involvement of L-Type
VSCCs in immature acetylcholine (Ach) neurotransmitter release (Sugiura and Ko, 1997).
Furthermore, L-Type VSCCs are localized on early migrating axons along with their growth
cones developmentally regulating acetyl choline (Ach) release from immature neurons (Sun and
Po, 1987; Zakharenko et al., 1999). We hypothesize, that these findings suggest in early
development, immature neurons in distinct brain regions may developmentally express more LType VSCCs as a compensatory mechanism when exposed to competitive antagonists, including
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Pb2. These Pb2+ induced perturbations of Ca2+ signaling may alter spontaneous and evoked
neurotransmitter release resulting in aberrant synaptogenesis during critical periods of neural
development (For Review See Rice and Barone Jr., 2000); consistent with Goldstein’s (1992)
hypothesis of Pb2+ disrupting synaptogenesis and developmental plasticity.
1.4-Pb2+ competition with Ca2+ through L-type VSCCs: Inhibition of neurotransmission
Pb2+ has been shown to compete with Ca2+ influx altering signal processing. In particular
the L-type VSCCs are critical for neurotransmission, gene induction, neuronal guidance in early
development, synaptogenesis and synaptic plasticity. Pb2+ mechanisms of cellular action have
been closely linked to mimetic properties of Ca2+ signal activation (Audesirk and Tjalkens,
2004). Thus, Pb2+ disrupts events that maintain Ca2+ cellular homeostasis. In particular Pb2+ has
been shown to inhibit voltage-sensitive calcium channels (VSCCs) (Saliba et al., 2009),
disrupting Ca2+ ionic gradient and electrochemical driving forces (i.e. typically 2mM:[Ca2+]e vs.
50-200nM:[Ca2+]i), and inducing aberrant cellular depolarization (Audesirk and Tjalkens, 2004).
Greenberg et al., (1986) discovered that neuronal excitability can regulate gene
transcription via the binding of agonists to the nicotinic acetylcholine receptor (nAchR), which
induced membrane depolarization and subsequent Ca2+ influx through VSCCs increasing c-fos
proto-oncogene expression in neural cell lines. Interestingly, Pb2+ has been shown to reduce Ca2+
influx through L-type VSCCs via competitive action (Büsselberg et al., 1991; Evans et al., 1991;
Tsien et al., 1988) Thus, L-type VSCCs competition with Ca2+ influx Pb2+ can reduce
neurotransmission efficiency, alter membrane excitability, and essentially alter gene regulation.
In the cytosol, Pb2+ influx through VSCCs may alter the phosphorylation levels of second
messenger-activated systems such as: Ca2+/calmodulin-dependent kinase (CAMKII),
Ca2+/calmodulin-dependent kinase-IV (CAMKIV), PKC, PKA, MAPK, and extracellularregulated kinases (ERK) (For Review See Toscano and Guilarte, 2005); therefore, indicating a
complex Pb2+ disruption of second messenger systems causing early developmental learning and
memory disruption. It is noteworthy to consider that if the expression and function of L-type
VSCCs are disrupted by Pb2+, then subsequent altered down-stream signaling cascades during
early brain development may result in premature or delayed developmental gene expression
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patterns consistent with early theories of Pb2+-induced disruption of synaptogenesis proposed by
Goldstein (1992).
1.5-Pb2+ reduces GABA neurotransmission through inhibiting presynaptic VSCCs
Of the many Pb2+ studies pertaining to learning and memory impairments in animals,
glutamate systems have been the major focus (For Review See Toscano and Guilarte, 2005) due
to the NMDARs involvement in calcium-dependent LTP as a cellular form of learning and
memory (Bliss and Collingridge, 1993). Squire (1992) initially observed that the hippocampus is
a fundamental brain region that regulates learning and memory, which further encodes the
cellular properties of LTP in its intrinsic circuits. Lasley and Gilbert (2000) suggested that Pb2+depressed LTP in hippocampus, suggesting a cellular correlation of cognitive learning
impairments. Notably, these observations failed to report a clear mechanism within the
hippocampal circuit responsible for explaining Pb2+ disruption in learning and memory.
Moreover, these studies solely focused on glutamatergic pathways, whereas GABAergic
interneurons provide critical synchronization of distinct neuronal rhythms between the
hippocampus and other integrative brain structures essential for learning and memory (Soltesz
and Deschenes, 1993; Bragin et al, 1995; Buzaki and Chrobak, 1995). Moreover, NMDARs,
GABAARs, and VSCCs collectively drive early brain Ca2+ oscillations through giant depolarizing
potentials (GDPs) to synchronize brain activity across structures; whereby they shape the timing
and tonic phases of excitation-inhibition balancing (Ben-Ari, 2002) prior to the onset of
glutamatergic synapse formation in the brain (See Figure 6.).

12

Figure 6. Neurodevelopmental trajectory and GDP critical period illustrating GABAergic
neurons preceding the onset of functional glutamatergic synapse formation [Adapted from BenAri et al., (2007)].
When hippocampal GABAergic activity is desynchronized, the resultant effects may
produce seizures due to improper GABA inhibition-to-glutamate excitation ratios. These critical
neuronal discharges balances in the hippocampus are disrupted by high BLLs (For Review See
Lidsky and Schneider, 2003). Pb2+ exposure decreases the threshold for membrane
depolarization, making neurons easily excitable, and increases hyper-excitability and potential
seizure activity. In a case study by Healy et al., (1984) an infant with Pb2+ neurotoxicity suffered
seizures associated with their poisoning, in which valproic acid was prescribed to control
convulsive activity successfully. Valproic acid enhances GABA synaptic transmission through
inhibiting the enzyme responsible for breaking down GABA, GABA transaminase. Thus,
valproic acid increased GABA neurotransmission reducing postsynaptic neuronal excitability
and increasing seizure thresholds in this child.
Krishnamoorthy et al., (1993) elegantly showed in rats that Pb2+ exposure increased
seizure onset and induced more severe convulsions induced by selectively blocking the GABAAR
with picrotoxin; thereby reducing GABA efficiency and increasing hyperexcitability. Taken
together, these studies indicate that the effects of Pb2+ exposure on the GABAergic system are
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equally important with respect to learning, memory, and seizure susceptibility as are the
glutamatergic systems. However, the GABAergic system must be carefully considered due to its
synapse formation arising prior to glutamatergic systems in early development.
To further support the claim that Pb2+ inhibits GABA neurotransmission, nerve terminal
preparation studies, otherwise known as synaptosomes, have been widely used to focus solely on
transynaptic communication. Ca2+ influx through VSCC regulates the liberation of
neurotransmitters from presynaptic nerve terminals (Turner et al., 1993). In synaptosomal
preparations, Pb2+ enters isolated nerve terminals and is further sequestered in mitochondria
(Silbergeld et al., 1977). Previously, Regunathan and Sundaresan, (1985) conducted
synaptosomal studies under Pb2+ treatments and observed reduced postsynaptic glutamate
binding and presynaptic uptake from rat cortex, cerebellum, and brainstem.
Jablonska et al., (1994) showed that chronically Pb2+-treated rats have decreased GABA
uptake, increased dopamine uptake that were independent of Ca2+ concentrations, with
morphological changes in the synaptic vesicles and mitochondria. Pb2+ has been shown to induce
biphasic properties where it inhibits depolarization-evoked release (i.e. increasing the neurons
threshold to fire specific chemical signals) and increases spontaneous release (i.e. increasing
non-specific neurotrophic factors and neurotransmitters) from rat hippocampal synaptosomes
(Minnema et al., 1988). These biphasic properties have shown that low concentrations of Pb2+
increases spontaneous neurotransmitter release and block depolarization dependent
neurotransmitter release across transmitter systems (Goldstein, 1980).
To further elucidate Pb2+ toxicity and the relationship between glutamate/GABAglutamine cycles with respect to neuronal-astrocyte excitability, synaptosomal studies
investigated GABA binding release and uptake. Neurons cannot synthesize glutamate or GABA
from glutamate decarboxylase (GAD) and must rely on astrocyte uptake through transport
proteins to convert these neurotransmitters into glutamine via catabolism of GABA transaminase
and succinate-semialdehyde dehydrogenase. Strużyñska and Sulkowski, (2004) showed
diminished GABA transport, decreased uptake and depolarization evoked release, lower
expression of GAD, the GABA synthesizing enzyme, and over expression of the GABA
transport protein GAT-1. Their work implicates another supporting argument for TiffanyCastiglioni’s (1989) 'lead sink' hypothesis, that Pb2+ may disrupt both glutamate and GABA
transporters activity and altered neuronal-astrocyte glutamine interactions, reducing GAD levels.
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Astroglia are critical for glutamate/GABA-glutamine metabolism and Pb2+ disruption of this
pathway as may result in cognitive impairments and seizure susceptibility. Importantly,
Strużyñska and Sulkowski, (2004) used only rat forebrain preparations, which may not
generalize towards region specific differences, but should be interpreted with caution. Spence et
al., (1985) showed that acute Pb2+ exposure reduced KCl dose-dependent GABA release from
spinal cord synaptosomal preparations. Pb2+ inhibition of GABA release from synaptosomes
(Minnema and Michaelson, 1986; Strużyñska and Rafalowska, 1994) and GABAergic
hippocampal neurons in culture (Braga et al., 1999) were also reported. In chronic Pb2+ treated
synaptosomes, GABA release was altered as a function of dose and duration (Minnema and
Michaelson, 1986; Strużyñska and Sulkowski, 2004; Lasley et al., 1999; Lasley and Gilbert,
2002).
Borisova et al., (2011) proposed that presynaptic disturbances induced by Pb2+ may cause
partial dissipation of the synaptic vesicle proton gradient resulting in decreased VSCC dependent
neurotransmitter release, incomplete vesicle filling with transmitter substances, and inhibition of
the Na+-dependent glutamate transporter. These results may also explain the increase in
spontaneous neurotransmitter release under Pb2+ exposure. VSCC inhibition has been well
documented as the best reported mechanism for presynaptic inhibition (Giustizieri et al., 2005).
Xiao et al., (2006) has shown that Pb2+ induces direct inhibition of VSCC in developing
hippocampal slices attenuating action potential dependent GABA release as a more precise
mechanism for Pb2+ neurotoxic cognitive impairments in early development.
1.6-The GABA shift is developmentally regulated by the Ca2+-dependent gene induction
of the KCC2-cotransporter
The GABA shift is defined as the developmentally regulated switch between early
immature neurons responding to GABA neurotransmission with excitation-to-mature neurons
responding to GABA neurotransmission with inhibition (Ben-Ari, 2002). There are two Ca2+dependent inducible Slc genes (i.e. solute carries that transport molecules across the cell
membrane) critical for developmentally regulating the GABA shift: (1) the gene that encodes for
the Na+-K+-Cl-Cl-cotransporter (NKCC1) is Slc12a2 and (2) Slc12a5 for the K+-Cl-Clcotransporter (KCC2). These genes arise from a family of electroneutral cation-chloride
cotransporters that were originally characterized in Drosophila melanogaster (Sun et al., 2010).
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This gene family is responsible for maintaining cell volume regulation, epithelial transport, and
GABAergic circuitry (Kahle et al., 2010). The latter sets the stage for appropriate GABAergic
and glutamatergic regulation of neural development in organisms.
In the mature brain the two major neurotransmitters, GABA and glutamate, mediate a
balance between excitation and inhibition of neuronal networks, respectively. However, in the
immature brain the GABAergic system is initially excitatory and precedes the subsequent
functional excitatory activity of the glutamatergic system due to a large chloride [Cl-]i when
compared to the [Cl-]e (Ben-Ari, 2002; Ben-Ari et al., 2007) (See Figure 7.).

Figure 7. The Cl- concentration and electrochemical gradients that maintain early GABAergic
excitation and mature inhibition based on the NKCC1 and KCC2 Cl- transport proteins [Adapted
from Ben-Ari et al., (2007)].
Therefore, presynaptic GABA secreting neurons can excite immature post synaptic
neurons expressing GABAAR’s, as long as the threshold is below ECl- and the driving force of Clremains at higher intracellular concentrations. This critical developmental process is regulated by
synergistic activity between VSCC and GABAAR’s. Ca2+ influx through VSCCs depolarize
neurons, activate GABA receptor permitting the efflux of Cl- inducing further depolarization
16

evidencing synergistic activity between VSCCs and GABAAR’s Following VSCC and GABAAR
synergistic action, GABA neurotransmission excites post synaptic cells, in turn, activating
NMDARs. NMDARs facilitate synchronized activity between the Ca2+ wave oscillations and
GDPs; which have been identified as the hallmark principle for developing neuronal networks
(Ben-Ari, 2002). The major regulators of the GABA excitation-to- inhibition shift are the KCC2
cotransporters. The shift is a Ca2+-mediated process in which KCC2 cotransporters are expressed
as a result of VSCC activation secondary to GABA-mediated depolarizations (Ben-Ari, 2002).
Thus, it is prudent to evaluate Pb2+ effects on KCC2 expression during the GABA shift in early
development.
The developmental shift in GABA from excitation in immature neurons to inhibition
when neurons mature, are developmentally regulated by the expression levels of NKCC1 and
KCC2 (Sun et al., 2010) and their subsequent functional activity. In early development NKCC1
cotransporters are highly expressed and very active, while the KCC2 cotransporters have a
relatively low expression level and are primarily inactive (Gamba, 2005). As the immature
neurons are releasing spontaneous GABA to remain viable and functional they also maintain
their cued guidance via neurotrophic factors in conjunction with long-range secretions by their
target cells. Once these immature neurons are fully guided to their fate destination they begin to
signal GDPs which allow higher conductances of Ca2+ influx due to the cooperativity from the
initially inactivated α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor (AMPARs)
and NMDARs.
To further evidence the KCC2 cotransporters regulating the GABA shift, studies in
culture evaluated excitatory GABAergic cells that were injected with KCC2 cotransporter
mRNA. The results indicated a shift from GABA excitation-to-inhibition in response to the
increase in KCC2 expression. The shift was determined to be a GABA mediated process in
which KCC2 cotransporter responded with feedback to the GABAARs (Ben-Ari, 2002).
Interestingly, when immature neurons were exposed to GABAAR antagonists the GABA shift
was prevented, but resulted in a peculiar effect in that KCC2 cotransporters were not affected
(Ben-Ari, 2002). Therefore, the KCC2 cotransporter activity and its expression in relation to
brain maturation remain to be elucidated. This indicates that the KCC2 cotransporter activity
may be regulated by PKA (Gomez-Ospina et al., 2006) through VSCCs (Ben-Ari, 2002) that can

17

stimulate by Pb2+ at nanomolar concentrations (Bressler et al., 1999) prematurely establishing
inappropriate neural network signals altering GABA excitation-to-inhibition.
1.7-Pb2+ alters immediate-early gene induction via the L-type VSCC
VSCCs maintain their precise spatio-temporal expression and signal functions through
principally conserved biophysical properties: (a) they are highly voltage dependent allowing for
rapid activation and inactivation of the channel pore which permits Ca2+ influx in response to
changes in membrane potential, (b) they are highly permeable to Ca2+ in contrast to other
potential ions, (c) VSCCs must be localized in areas on neurons where they can easily access
relevant regulatory targets of Ca2+-dependent signaling cascades; thus allowing for rapid
localized increases in [Ca2+]i, (d) lastly, they must undergo modulation and diverse
conformations to permit selective regulation of different classes of VSCCs (Tsien and Barrett,
2005).
Moreover, Pb2+ can influx into the cytosol in bovine adrenal medullary cells through Ltype VSCCs (Sun and Suszkiw, 1995; Simons and Pocok, 1987). Once Pb2+ invades the
intracellular cytosol it is able to perturb L-type VSCCs kinetics by increasing ICa through
attenuation of the calcium-dependent steady state inactivation of the L-type VSCCs (Sun and
Suszkiw, 1995). In response to cytosolic Pb2+ increasing Ca2+ conductance, the subsequent
increase in [Ca2+]i results in rapid and prolonged second messenger system activation, and
ultimately third messenger gene induction affecting an array of regulatory protein transcription
factors such as CREB (Toscano et al., 2003; Toscano et al., 2002), NR1 (Toscano and Guilarte,
2003; Nihei and Guilarte, 1999; Guilarte and McGlothan, 1998), c-fos and jun (Toscano and
Guilarte, 2005; Finkelstein, Markowitz, Rosen, 1998), and brain derived neurotrophic factor
(BDNF) (Schneider et al., 2001); all of which resulted in altered mRNA expression levels for
each of these target genes in response to Pb2+ exposure. In addition, internal endoplasmic
reticulum stored of Pb2+ may be released into the cytosol activating second messenger systems
altering gene activity; otherwise, cytosolic Pb2+ can activate hormonally regulated G-proteins
that stimulate VSCC activity (Nussey and Whitehead, 2001).
More recently, Schneider et al., (2011) investigated the effects of a 30-day postnatal Pb2+
diet in the rat and changes in hippocampal gene expression via microarray analyses. They found
that Pb2+ may differentially affect gender; one gene in male rats, the extracellular face hand
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calcium binding domain (Efcab1), had a significant10-fold increase in response to Pb2+
treatment, whereas females exhibited a significant 0.6-fold reduction in hippocampal gene
expression (Schneider et al., 2011). Ca2+ signaling can be either indirectly activated by Ca2+dependent kinases and phosphatases regulating transactivating properties of transcription factors
(Dolmetsch et al., 2001 West et al., 2001; Kornhauser et al., 2002; Spotts et al., 2002) or directly
via nuclear Ca2+ sensors (Leclerc et al., 2012).
Currently, a Ca2+-dependent DNA regulating transcription factor is the downstream
regulatory element antagonist modulator (DREAM); derived from the recoverin 4-EF hand
subfamily, involved in transcription repression (Carrion et al., 1999; Mellstrom and Naranjo,
2001). Moreover, a unique concept for VSCCs arose, whereby the Ca2+ domains may act in a
functional way as a self regulating transcription factor, such as the Cav1.2 C-terminal fragments;
otherwise known as the Ca2+-channel associated transcriptional regulator (CCAT) (GomezOspina et al., 2006). The CCAT has been shown to translocate to the nucleus, regulate gene
expression, and increase dendritic arborization once activated (Gomez-Ospina et al., 2006).
Schneider et al., (2011) identified 175 genes that were differentially regulated in response to Pb2+
and gender further altered expression patterns, which may have resulted from Pb2+ alterations in
CCAT regulation. NMDAR2A mRNA in the developing hippocampus of gestational Pb2+ treated
rats (Nihei and Guilarte, 1999), and mRNA NR1 splice variants were reported to variably alter
hippocampal expression in all cornu ammonis (CA) regions when compared to controls in
response to gestation and developmental Pb2+ exposure evidencing altered synaptogenesis
(Averil et al., 1980; McCauley et al., 1982; Kawamoto et al., 1984; ) and negatively effecting
learning in these rats (Guilarte et al., 2000; Guilarte and McGlothan, 2003).
In primary neuronal cultures, treatment with Pb2+ (10µM-100µM) inhibits NMDAR
activity during the critical stage of synaptogenesis resulting in altered glutamatergic connectivity
later in life (Neal et al., 2011). These data may indicate that alteration in the glutamatergic
system induced by lead may result in aberrant connectivity in the brain. Despite the importance
of Ca2+ channels being localized near NMDAR in cells and their synergistic actions in learning
and memory, NMDARs during early development are present but inactive leaving only
GABAARs and VSCCs as mediators of excitation. Not until the GABA shift is completed in
early development do the NMDARs take on a sequential role in regulating Ca2+ activity to
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synchronize GDPs as the molecular substrate for initially hard wiring the brain and subsequently
establishing the networks for experience dependent learning and memory.
Given this information it is prudent to evaluate the potential for Pb2+ to alter the
expression of genes critical in early GABA development prior to the activation of the NMDARs
and the establishment of functional neuronal circuits. Here, we hypothesize that in response to
gestational Pb2+ exposure in the rat the Slc12a family genes that regulate the timed expression of
the NKCC1- and KCC2-transporters are disrupted. These transporters regulate the
developmental changes in GABAergic excitation-to-inhibition. Therefore, alteration in the
expression pattern would interfere with critical periods of brain development. The potential for
aberrant synaptic connections prior to the NMDAR system being activated would suggest that not
only are glutamatergic neurons susceptible to Pb2+ insult, but GABAergic neurons may be
equally affected prior to glutamatergic neurons. However, given the importance of the GABA
system in early neural development, it may be more informative in elucidating the molecular
mechanisms of Pb2+ action on the GABAergic neural development.
Studies by Murphy et al., (1991) and Deisseroth et al., (1996) showed that in the presence
of pharmacological agents that block L-type VSCCs, inhibition of immediate-early gene inducers
occurs. Therefore, the influx of Ca2+ is responsible for immediate-early gene induction,
indicating that any disruption of this signaling pathway, such as those produced by Pb2+, may
result in altered immediate-early gene induction consistent with published data (Schneider et al.,
2011).
The findings from the aforementioned studies in accordance to our hypothesis suggest the
following signaling cascade of Pb2+ resulting in altered gene induction during early development
(See Figure 8.):
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Figure 8. Hypothesis Model Pb2+ Competition Through VSSCs Reduces β3 Subunit
Autoregulation of Cell Excitability Reducing Gene Regulation Resulting in Developmental
Delays.
1) Pb2+ may compete with Ca2+ influx through the L-type VSCCs; 2) intracellular Pb2+
may increase the ICa through VSCCs by delaying its ability to inactivate the channel; 3) increased
[Ca2+]i in response to Pb2+ may alter the activity of gene induction pathways through a) sustained
Ca2+-dependent activity with second messengers or alternatively b) Pb2+ may directly activate
third messengers altering DNA; and 4) Pb2+ may alter transcription factors of the VSCCs as a
self-regulating mechanism in response to Pb2+ exposure. The VSCCs-β3 subunit (CCAT) upon
neuronal excitation, translocates from the membrane to the nucleus and transcribes mRNA
coding from the VSCCs gene CACNB β3 (Bros et al., 2011; Satin, et al., 2011).
Thus, this signaling serves as an autoregulatory process in neurons through a distinct Cterminal encoding of a VSCCs-β3 subunit transcription factor in response neuronal excitability
(Gomez-Ospina et al., 2006). Moreover, VSCCs-β3 activity increases as a function of post natal
development and is highly expressed in GABAergic neurons in early development (GomezOspina et al., 2006). Thus, Pb2+ may disrupt this VSCCs-β3 autoregulation, resulting in altered
gene transcription, decreased Ca2+ signaling, and altering neurite formations and extensions
during the critical stages of early development.
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1.8-Postulated molecular mechanism of Pb2+ perturbation of GABAergic immediateearly gene induction via the L-type VSCC and reduced GABA release during
synaptogenesis.
The goal of this study was to investigate how chronic gestational Pb2+ exposure leads to a
neurodevelopmental delay in the rat model through a multi level system approach using
molecular, cellular, physiological and behavior analyses described as follows.


We hypothesized that Pb2+, through competition with initial Ca2+ influx and inhibition of
Ca2+-dependent processes, leads to premature increased expression of key regulatory
proteins directing the GABA shift resulting in premature wiring of neuronal circuits. To
evaluate this primary cerebellar neuronal cultures from harvested from postnatal day 6
rats were used as an in vitro model system. Chronic gestational Pb2+ exposure may
significantly alter the Ca2+-dependent activity and autoregulatory transcription and
translation of the VSCCs β-3 subunit expression resulting in perturbations in GABAergic
signaling and GDP-induced neuronal network miss-wiring and de-synchronization with
altered synaptogenesis in early development. We sought to evaluate the presences of
VSCC β-3 subunit nuclear translocation and relative GABAAR expression in cultured
cerebellar neurons to test our hypothesis. We hypothesize that Pb2+ attenuation of
VSCC's in early development produces an upregulation in CACNB β3 mRNA expression
channelopathies and a down regulation of GABAARs β-3 chain mRNA expression, which
is associated with neurodevelopmental disorders such as schizophrenia and autism (Hyde
et al., 2011; Khale et al., 2008). In order to assess these changes we sought to
characterize the altered mRNA expression of the KCC2 transporter, which is responsible
for shifting from GABA excitation-to-inhibition, mRNA for GAD isoforms GAD80,
GAD86 (i.e. as markers for early excitatory GABAergic events) GAD65, and GAD67 (i.e.
as markers for mature inhibitory GABAergic events), NKCC1 (i.e. a marker for early Climporters regulating GABAergic excitation), KCC2 (i.e. a marker for late Cl- exporters
regulating GABAergic inhibition), GABAAR β-3 (i.e. a GABAergic marker for inhibitory
regulation of fear learning and memory and a susceptibility marker for autism
neuropathology), CACNB β3 (i.e. a marker for L-Type VSCCs β-3 subunits to assess
nuclear transcription), MECP2 (i.e. a marker for presynaptic neurotransmitter release),
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and FMR1(i.e. a marker for postsynaptic plasticity through mGlurs) in response to Pb2+
exposure.


We predict that the effects of Pb2+ on these genes are age- and brain region-dependent.
We will investigate the Pb2+-induced changes in the whole frontal cortex and
hippocampus to assess the spatial and temporal distribution of CACNB β3 and GABAAR
β-3 across development.



We postulate that the aforementioned altered molecular mechanisms of action in response
to Pb2+ neurotoxicity may result in enhanced brain excitability resulting in increased
spontaneous neurotransmitter release during early development, attenuation of evoked
neurotransmitter release, disrupted synaptic activity with respect to presynaptic vesicle
liberation and post synaptic modification impairing early synaptogenesis. We hypothesize
that gestational Pb2+ exposure will produce alterations in spontaneous and evoked
neurotransmitter release, transmitter uptake, and postsynaptic binding of transmitter
substances.



Consistent with these disruptions in age-dependent frontal cortex and hippocampal brain
plasticity induced by gestational Pb2+ exposure aberrations in experience dependent
learning and memory, negative effects on emotionality and disruption in reversal and/or
inhibitory learning (i.e. either by prefrontal cortical disinhibition or over excitation)
(Burtkowski, 1964) behavioral consequences are expected. In addition, we will assess the
potential recovery on Pb2+ induced disruptions by GABAergic agonists as a potential
pharmacotherapeutic intervention for Pb2+ toxicity. Together the aforementioned effects
may help explain the initial stages of Pb2+ induced perturbations of early GABAergic
development prior to the onset of the AMPARs and NMDARs role in learning and
memory.

The delicate interplay between both the GABAARs and VSCCs when challenged by chronic
gestational low level Pb2+ exposure do not result in organism death. Thus, biochemical
compensations exist in response to this Pb2+ neurotoxicity that, in turn, produces altered brain
wiring and synaptogenesis underlying the aforementioned behavioral outcomes produced in our
rat model.
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2.0-Chronic Gestational Pb2+ exposure produces a high BLL that remains throughout
development

2.1-Methods

2.1.1-Subjects
Long-Evans Norwegian hooded male and female rats were paired. Control rats were fed a
regular Purina rat chow (Dyets Inc. # 61212) [containing 970gm/Kg Purina RMH 1000 chow,
30gm/Kg maltose dextrin], while the pairings for Pb2+ rats were fed a diet containing 1.5g/Kg
lead acetate (Dyets Inc. # 612113) [containing 968.4gm/Kg Purina RMH 1000 chow, 30gm/Kg
maltose dextrin, 1.5gm/Kg lead acetate, and 0.1gm/Kg yellow dye] (956ppm) ad libitium from
pairing throughout gestation and continued through parturition and weaning at 21 days of age..
At postnatal day (PND) 2, 7, 14, and 22 rats (N = 5) were anesthetized with 50mg/kg Nembutal®
i.p., transcardial blood samples were collected, then rats were sacrificed and whole brains were
taken in accordance with The College of Staten Island (CUNY) IACUC approval. Dams of the
pups (n = 3) were also sacrificed at the same time to track whether or not BLL concentrations
changed as a function of age and/or their relationship to the mother’s level of Pb2+ toxicity.
Additionally, rat brains were harvested, Cryoprotected (or homogenized) and stored at -80ºC for
further processing of proteins.

2.1.2-Blood lead level analyses

At the point of animal sacrifice transcardial blood samples were collected in
ethylenediaminetetraacetic acid (EDTA) coated S-Monovette® syringes (Sarstedt, Germany)
mixed and immediately frozen on dry ice. Samples were then sent out for BLL determination to
Magellan Diagnostics (North Bellirica, MA). BLLs were determined using atomic absorption
spectrophotometry (AAS) with a sensitivity detection level of 1µg/dL.
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2.1.3.-Statistical analyses
All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK). An Age X Subject
and an Age X Treatment ANOVA were used to identify factor and interaction effects. Significant
differences were determined by an equal N Tukey’s HSD post hoc comparison test. Significance
levels were set at p < 0.05 with a SEM of 95%. Data are presented as mean ± SEM.

2.2.-Results
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Figure 9. Dams and pups BLL subject comparisons as a function of age. Pups at PND 2 had
increased BLLs when compared to their dams. Following PND 2 a reversal of BLL profiles
were observed and remained until PND 22 where both subjects leveled off.
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Figure 10. BLL treatment comparisons as a function of age during development. Control rats
were Pb2+ negative throughout development. There was a significant difference in Pb2+ treated
rats in all ages when compared to controls (p<0.001***). Pb2+ treated rats showed significant
differences at PND 7 (p<0.001***) and 14 (p<0.001***) when compared to PND 2 rats. In
addition, the Pb2+ rats showed an inverted curvilinear relationship in elevated BLLs at PND 2
and 22, suggesting a difference in absorption from early lactation feeding, relative rat blood
volume and ability to independently feed from the food cages at PND 22.
The influence of a 956ppm Pb2+ gestational diet (i.e. from birth to sacrifice) resulted in
pup mean blood lead levels (BLLs measured in μg/dL) at PND 2= 41.83 SEM± 14.17, PND 7=
34 SEM± 10.4, PND 14= 30.17 SEM± 7.77 and PND 22= 38.67 SEM±10.67. The dams at
corresponding Pb2+ exposure times evinced mean BLLs at PND 2= 37 SEM± 9, PND 7= 41.33
SEM± 21.33, PND 14= 39.33 SEM± 60.33 and PND 22= 43.6 SEM± 22.3 respectively.
In contrast, control pups and dams were Pb2+ negative.BLL samples revealed an Age
effect (DF=3, MS=66.81, F=4.128, p<0.01**) and Subject effect (i.e. Dam or pup) (DF=1,
MS=147.62, F=9.121, p<0.01**) (See Figure. 9.). Moreover, an Age X Subject interaction was
observed (DF=3, MS=77.88, F=4.8, p<0.01**) (See Figure 9.). Figure 10. shows the
differences in BLLs based on treatment conditions having an Age effect (DF=3, MS=79.06,
F=14.708, p<0.001***) a Treatment effect (DF=1, MS=14,840.33, F=2,760.99, p<0.001***) and
an Age X Treatment interaction (DF=3, MS=779.06, F=14.71, p<0.001***).
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2.3.-Discussion

Figure 9. shows that at PND 2 pups had an elevated BLL (~ 42μg/dL) in contrast to their
dams (~ 37μg/dL) and at PND 7 these observations reversed in that the dam had elevated BLLs
(~42μg/dL) when compared to their pups, whose BLL dropped remarkably (~34μg/dL). These
reversed BLLs/age ratios persisted throughout postnatal development (PND 7-14), whereas at
weaning (PND 22) pups BLLs were quite similar (~ 39μg/dL) to that of their respective dams
(~43μg/dL). These results suggest that rat pups were vulnerable to Pb2+ exposure and
accumulated more Pb2+ at PND 2 during critical stages in early development. Notably, at PND 7
there was a decrease in pup BLLs, which may be due to either increased excretion, but was more
likely due to brain/body deposition. If early brain Pb2+ deposition was highest at PND 7 it would
suggest that this age in postnatal development may contribute considerably to altering the critical
periods in early brain development and further disrupt fine tuning and wiring during
synaptogenesis at PND 14. Lastly, the decrease in BLLs from PND 2 through 14 and increase in
BLLs from PND 14 to 22 could be explained by the rats’ respective weight to blood volume ratio
as a function of age and the pups independence of eating leaded food (See Figure. 9.). In
addition, at PND 2 the Dams milk is more concentrated and may contain more Pb2+ that is
readily absorbed when compared to later postnatal ages. Figure 10. illustrates that there were no
BLL concentrations detected above or below the 1µg/dL range in control rats irrespective of age.
Notably, the rats exposed to Pb2+ showed significant body burdens with highest levels at PND 2
and 22 evinced by an inverted curvilinear relationship as a function of age.
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3.0-Pb2+ exposure alters Ca2+-dependent GABA shift: Novel mechanism for early Pb2+
induced neuropathology via altered GABA brain networks:

3.1-Methods

3.1.1-Subjects

Experimentally naïve male Long Evans Norwegian Hooded rats (Taconic, N.J.) (Control
n = 12; Pb2+ n = 12; n = 3 for PND 2, 7, 14, and 22) were maintained under controlled
temperature (24 ± 1°C) and humidity (55 ± 5%), on a 12-hr light (17:00–7:00 hr):12-hr dark
(7:00–17:00 hr) cycle. Lead was administered as described in section 2.1.1. Age-matched
controls were used as a reference group.

3.1.2-Sample preparation

At PNDs 2, 7, 14, and 22 rats were selected from each treatment condition (i.e. N = 3) for
brain extraction of both frontal cortices and hippocampi respectively. Briefly, rats were
anesthetized with Nembutal® (i.p. injection 50mg/Kg) and sacrificed in accordance with The
College of Staten Island’s IACUC approval procedures. Their frontal cortices and hippocampi
were homogenized and phenol: chloroform extracted in less than 2 minutes and frozen on at 80ºC until use.
3.1.3-RNA preparation
RNA was prepared from brain tissue samples in accordance with manufactures’ protocol
(TRIzol Reagent; Invitrogen 15596-026). Briefly, 50-60mg of wet brain tissues were weighed
and homogenized in 1ml of TRIzol regent per 100mg of tissue using a glass-Teflon for 1 hr. Post
centrifugation, RNA was subjected to a chloroform extraction and subsequently precipitated with
isopropyl alcohol. RNA samples were then resuspended in 100µl of DEPC-treated H2O.
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3.1.4-Preparation of cDNA and real-time PCR analysis
Identical amounts of total RNA (i.e. 10µg) were treated with RNase-free DNase (Qiagen
cat. #79254) at 37°C for 1 hr and purified by phenol/chloroform extraction (i.e. 3:1) followed by
an ethanol precipitation. From the purified RNA, 1µg was used in the SYBR GreenER Two-Step
qRT-PCR kit (Invitrogen cat. #11765-100) for the first strand cDNA synthesis and in the realtime PCR reaction preparation according to the manufactures protocol. The real-time PCR
primers are noted in Table 1. All experiments were repeated three times. In addition, within each
experiment PCR reactions were done in triplicates and analyses conducted through a 7500
sequence detection system (Applied Biosystems).

Table 1. Oligonucleotides used in the real-time qRT-PCR reactions.
GAPDH ORF
Forward primer

5’-ACAGGGTGGTGGACCTCATG-3’

Reverse primer

5’-GTTGGGATAGGGCCTCTCTTG-3’

GAD 80 ORF
Forward primer

5’-AGTGTGGCCTCCAGAGGTTC-3’

Reverse primer

5’-TGGATATGGCTCCCCCAGGAG-3’

GAD 86 ORF
Forward primer

5’-TGGCCTCCAGAGGTGATGGT -3’

Reverse primer

5’-TGGATATGGCTCCCCCAGGAG -3’

GAD 65 ORF
Forward primer

5’-GGCTCTGGCTTTTGGTCCTTC -3’

Reverse primer

5’-TGCCAATTCCCAATTATACTCTTGA -3’

GAD 67 ORF
Forward primer

5’-GCTGGAAGGCATGGAAGGTTTTA-3’

Reverse primer

5’-AATATCCCATCACCATCTTTATTTGACC -3’

GABAA β3 ORF
Forward primer

5’-CCACGGAGTGACAGTGAAAA-3’

Reverse primer

5’-CACGCTGCTGTCGTAGTGAT-3’

CACNB β3 ORF
Forward primer

5’-TGGATCGGGAGGCTAGTGAA-3’
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Reverse primer

5’-CACGCTGCTCGTAGTGAT-3’

NKCC1 ORF
Forward primer

5’-ATGAGTCTTCCAGTTGCCCG-3’

Reverse primer

5’-GCAACGTGTCCATGTGCTTT-3’

KCC2 ORF
Forward primer

5’-GGACCCCCGCATACAAAGAA-3’

Reverse primer

5’-CCTCCAGACCTTGTGGTGAC-3’

MECP2ORF
Forward primer

5’-CAGGTCATGGTGATCAAACG -3’

Reverse primer

5’-CCACACTCCCAGGCTTTCTA-3’

FMR1ORF
Forward primer

5’-GTGAGATTCCCACCACCTGT -3’

Reverse primer

5’-CCAACAGCAAGGCTCTTTTT -3’

3.1.5-Target DNA sequence estimations

Target DNA sequence quantities were estimated using the procedures described by
Andrew et al., (2012); Ford et al., (2007); Wimalarathna et al., (2011), and Zhang et al., (2009).
Briefly, the target DNA sequence quantities were estimated from the threshold amplification
cycle number (CT) using Sequence Detection System Software (Applied Biosystems). A ΔCT
value was obtained by subtracting the respective primer CT value from the CT value from the
corresponding glyceraldehyde 3-phosphate dehydrogenase (GAPDH) value in order to
normalize the differences in cDNA aliquots as a house keeping gene. Therefore, the relative
mRNA levels were expressed as 2(-Δ CT) X 100% of GAPDH and data transformed to a Log10
value for fold change comparisons.
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3.1.6-Statistical analyses
All data were transformed from the relative mRNA 2(-Δ CT) X 100% of GAPDH to a
Log10 value to easily compare differences in fold expression. Data were then further analyzed in
Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK). An Age X Treatment X Gene ANOVA was used to
identify factor and interaction effects. Significant differences were determined by either an equal
or unequal N Tukey’s HSD post hoc comparisons test. Significance levels were set at p < 0.05
with a SEM of 95%. Data are presented as mean ± SEM.
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3.2-Results

Figure 11. Chronic gestational Pb2+ exposure down regulated Caβ3 mRNA expression in cortex
and hippocampus during early brain development. Cortical Caβ3 mRNA was down regulated
from PND 7 through PND22 (p<0.001***) (A). Hippocampal Caβ3 mRNA was down regulated
affected at PND 7 and 22 (p<0.001***), but recovered at PND 14 (B). GABA β3 mRNA was
down regulated at PND 22 in cortex (A) and hippocampus (B) in response to Pb2+ (p<0.01**).
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Figure 11. GABAAR’s showed that in cortex GABAAR-β3 and Ca β3 mRNA expression
changes induced by Pb2+ exposure caused a Gene effect (DF=1, MS=2.31, F=82.69,
p<0.001***) an Age effect (DF=3, MS=1.76, F=63.15, p<0.001***), a Gene X Age Interaction
(DF=3, MS=0.36, F=12.93, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.769,
F=27.55, p<0.001***) and a Gene X Age X Treatment interaction (DF=3, MS=0.21127,
F=7.565, p<0.001***) (A).
Figure 11. showed that in hippocampus GABAAR-β3 and Ca β3 mRNA expression
changes induced by Pb2+ exposure caused an Age effect (DF=3, MS=0.837, F=5.56, p<0.01**), a
Treatment effect (DF=1, MS=1.129, F=7.50, p<0.01**) a Gene effect (DF=3, MS=29.00,
F=192.58, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.96, F=6.35,
p<0.001***), an Age X Gene interaction (DF=9, MS=0.47, F=3.13, p<0.001***), a Treatment X
Gene interaction (DF=3, MS=0.68, F=4.53, p<0.006166) and an Age X Treatment X Gene
interaction (DF=9, MS=0.78, F=5.17, p<0.001***) (B).
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Figure 12. Chronic gestational Pb2+ exposure decreases KCC2 and increases NKCC1 mRNA in
cortex and hippocampus during early brain development. Cortical KCC2 mRNA is down
regulated from PND 7 (p<0.05*), through PND 14 (p<0.001***), whereas NKCC1 mRNA is up
regulated at PND 2 and 7 (A). Interestingly, in hippocampus the KCC2 mRNA is down regulated
at PND 2 through 7 (p<0.001***) and up regulated at PND 14 (p<0.05*), whereas NKCC1
mRNA is up regulated at PND 2 (B).
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Figure 12 showed that in cortex NKCC1 and KCC2 mRNA expression changes were
altered by Pb2+ exposure resulting in an Age effect (DF=3, MS=1.76, F=63.15, p<0.001***), a
Gene effect (DF=1, MS=2.31, F=82.69, p<0.001***), an Age X Treatment interaction (DF=3,
MS=0.77, F=27.55, p<0.001***), an Age X Gene interaction (DF=3, MS=0.36, F=12.93,
p<0.001***) and an Age X Treatment X Gene interaction (DF=3, MS=0.21, F=7.57,
p<0.001***) (A).
Figure 12 showed that in hippocampus NKCC1 and KCC2 mRNA expression changes
were altered by Pb2+ exposure resulting in an Age effect (DF=3. MS= 1.43, F=17.86,
p<0.001***), a Treatment effect (DF=1, MS=4.22, F=52.68, p<0.001***), a Gene effect (DF=1,
MS=0.92, F=11.46, p<0.001***) and an Age X Treatment interaction (DF=3, MS=0.36, F=4.48,
p<0.01**) (B).
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Figure 13. Chronic gestational Pb2+ altered early and late GAD mRNA expression levels.
Cortical Pb2+ exposure disrupted early GAD 80 and 86 and late GAD 67 mRNA expression at
PND 2 (p<0.01**) and altered late GAD 65 and 67 mRNA at PND 22 (p<0.001***) (A).
Hippocampal, early GAD 86 mRNA expression was up regulated at PND 2 (p<0.01**) and late
GAD 67 mRNA expression was down regulated (p<0.001***) (B).
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Figure 13. showed that in cortex early GAD 80 and 86 and late GAD 65 and 67 were
perturbed by Pb2+ resulting in an Age effect (DF=3, MS=3.11, F=34.66, p<0.001***), a Gene
effect (DF=3, MS=29.61, F=330.35, p<0.001***), an Age X Treatment interaction (DF=3,
MS=1.34, F=14.95, p<0.001***), an Age X Gene interaction (DF=9, MS=0.79, F=6.58,
p<0.001***), a Treatment X Gene interaction (DF=3, MS=0.59, F=6.58, p<0.001***) and an
Age X Treatment X Gene interaction (DF=9, MS=0.50, F=5.56, p<0.001***) (A).
Figure 13. showed that in hippocampus early GAD 80 and 86 and late GAD 65 and 67
were perturbed by Pb2+ resulting in an Age Effect (DF=3, MS=0.84, F=5.56, p<0.01**), a
Treatment effect (DF=1, MS=1.13, F=7.50, p<0.01**), a Gene effect (DF=3, MS=29.00,
F=192.57, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.96, F=6.35,
p<0.001***), an Age X Gene interaction (DF=9, MS=0.47, F=3.13, p<0.001***), a Treatment X
Gene interaction (DF=3, MS=0.68, F=4.53, p<0.01**) and an Age X Treatment X Gene
interaction (DF=9, MS=0.78, F=5.17, p<0.001***) (B).
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Figure 14. Chronic gestational Pb2+ effects on synaptic vesicle release MECP2 and synaptic
plasticity FMR1 mRNA expression levels. Pb2+ up regulated FMR1 mRNA expression levels at
PND 2 through 7 (p<0.001***) and down regulated expression levels at PND 14 (p<0.05*) in
cortex (G). Interestingly, FMR1 mRNA expression of MECP2 mRNA expression reversed at
PND 14 when comparing Pb2+ rats to controls (A). Pb2+ exposure down regulated FMR1 and
MECP2 mRNA expression at PND 7 and MECP2 mRNA expression at PND 22 (B).
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Figure 14.showed that in cortex FMR1 and MECP2 mRNA expression levels were
disrupted resulting in an Age effect (DF=3, MS=1.21, F=50.98, p<0.001***), a Treatment effect
(DF=1, MS=0.15, F=6.49, p<0.02*), a Gene effect (DF=1, MS=0.63, F=26.61, p<0.02*), an Age
X Treatment interaction (DF=3, MS=0.093, F=3.95, F=0.02*) and an Age X Gene interaction
(DF=1, MS=0.08, F=3.19, p<0.04*) (A).
Figure 14. showed that in hippocampus FMR1 and MECP2 mRNA expression levels
were disrupted resulting in an Age effect (DF=3, MS=2.48, F=32.73, p<0.001***), a Treatment
effect (DF=1, MS=0.47, F=6.2, p<0.02*), a Gene effect (DF=1, MS=0.63, F=8.36, p<0.01**)
and an Age X Treatment interaction (DF=3, MS=0.23, F=3.00, p<0.05*) (B).

3.3-Discussion
We examined Pb2+ effects on gene expression during early development in cortex and
hippocampus. The qRT-PCR data revealed that Pb2+ decreases VSCC- β 3 mRNA expression at
PND 7, 14, and 22 in cortex and PND 7 and 22 in hippocampus when compared to control rats
(Figure 11-A & B.). Pb2+ effected these genes differentially resulting in the VSCCs mRNA
down regulation in expression, whereas the GABAAR-β3 mRNA expression was observed to
increase in cortex at PND 2, 7, and 14 then decreased at PND 22 from control rats (Figure 11A.). Interestingly, in hippocampus the GABAAR-β3 mRNA expression was decreased at PND 7
and 22 under Pb2+ treatment (Figure 11-B.). These findings suggest that GABAAR-β3 mRNA
increases expression when VSCC- β 3 mRNA decreases in response to Pb2+ insult.
With respect to the chloride transport proteins that regulate the GABA-shift, we observed
increased NKCC1 mRNA expression at PND 2 and 7 in cortex (Figure 12-A.), whereas in
hippocampus an increase at PND 2 was noted and then a decrease at PND 22 when compared to
control rats (Figure 12-B.). The KCC2 mRNA was shown to decrease at PND 2 and increase at
PND 7 in both cortex (Figure 12-A.) and hippocampus (Figure 12-B.) when compared to
control rats. Notably, in cortex at PND 14 KCC2 mRNA expression was decreased (Figure 12A.), whereas in hippocampus it was increased under Pb2+ treatment (Figure 12-B.). These
findings suggest brain regions specific differences in the proteins required for the onset of the
GABA-shift were observed in cortex at PND 22 and in the hippocampus at PND 14 in response
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to Pb2+ exposure. However, the ratio of the NKCC1 and KCC2 transport proteins and their
functional activation through phosphorylation remain to be elucidated under Pb2+ exposure.
To determine how Pb2+ may affect early GABAergic neurons we investigated how early
GAD 80 and 86, as well as, late GAD 65 and 67 mRNA expression altered during post natal
development. We observed that in cortex GAD 80 and 86 mRNA expression increased at PND 2
and 14 when compared to control rats (Figure 13-A.). In hippocampus, GAD 80 mRNA
expression decreased at PND 2, whereas GAD 86 increased at PND 2 in response to Pb2+
treatment (Figure 13-B.). At PND 14 both GAD 80 and 86 increased in hippocampus when
compared to control rats (Figure 13-B.).
With respect to late GAD 65 we observed in cortex that mRNA expression increased
from PND 2 through 14 and decreased at PND 22 under Pb2+ exposure (Figure 13-A.). In
hippocampus, GAD 65 showed decreased mRNA expression at PND 2 and 7 in response to Pb2+
(Figure 13-B.). In cortex GAD 67 mRNA expression was observed to increase at PND 7 and
decrease at PND 22 (Figure 13-A.), whereas in hippocampus a decrease in GAD 67 mRNA
expression was observed at PND 7 and PND 22 (Figure 13-B.). These findings suggest that
Pb2+ interferes with early GAD 80 and 86 that prolong early GABAergic excitation during
development. Together, these findings show a direct effect of Pb2+ insult unto GABAergic
neurotransmission during critical stages of development with the temporal programming of
GABAergic networks at the transcriptional level.
In order to assess how Pb2+ would affect presynaptic neurotransmitter vesicular release
and post synaptic plasticity we evaluated the changes in mRNA expression for MECP2 and
FMR1 respectively during development. In the cortex, Pb2+ exposure caused increased MECP2
mRNA expression at PND 14 when compared to controls (Figure 14-A.). In hippocampus Pb2+
decreased mRNA expression in PND 7 and 22 (Figure 14-B.). In cortex FMR1 mRNA
expression was observed to increase in PND 2 and 7 followed by a decrease at PND 14 (Figure
14-A.), whereas in hippocampus decreased mRNA expression was shown at PND 7 in response
to Pb2+ (Figure 14-B.). These findings indicate that in cortex at PND 14 Pb2+ perturbs vesicular
release and post synaptic plasticity. In hippocampus at PND 22 Pb2+ disrupts vesicular release.
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4.0- Chronic gestational Pb2+ exposure reduces GABAAR expression developmentally and
causes nuclear translocation of the L-Type VSCCs β-3 subunit in cortex and hippocampus

4.1-Methods

4.1.1-Subjects

Experimentally naïve male Long Evans Norwegian Hooded rats (Taconic, N.J.) (Control
n = 12; Pb2+ n = 12; n = 3 for PND 2, 7, 14, and 22). Long Evans male and female rats were
paired. Rats were fed as described in section 2.1.1.

4.1.2- Brain slice immunohistochemistry

At postnatal day (PND) 2, 7, 14, and 22 rats were sacrificed and perfused 15 minutes
with PBS followed by 10 minutes 4% PFA. The following 24 hours, brains were transferred
into 30% sucrose in PBS. Brains were aligned to cut mid-sagittal sections on a cryostat with
O.C.T. TissueTek® compound at -26°C. Brain sections were cut in 30µm thick slices and
transferred to a 12 well plate with cryoprotectant 30% glycerol, 30% ethylene glycol, and 40%
PBS for floating immunohistochemistry (IHC). Repeated serial sections were collected in each
well to increase reliability of staining between slices. Slices were blocked with 2% NFDM-PBS,
10% NGS, and 0.02% Triton X100, washed for 30 minutes and blocked in same solution without
Triton X100 with primary antibodies MS x GABAAR beta chain (MAB341 Chemicon
International), MS x KCC2 (MyNeuroAb) and Rbt x Calcium 3 (AB5230-200Ulb Chemicon
International) then incubated for 24 hours at -4ºC. The following secondary antibodies were used:
goat anti-Ms FITC (ab’) 2 (Santa Cruz Biotechnology) and Cy5 goat anti-Rbt (Santa Cruz
Biotechnology). For confocal data, the FITC fluorophore was excited at 488 nm; the Cy5 at 633
nm. Emission for these dyes are in the green and red range, respectively. Slices were transferred
onto gelatin-coated slides manually and mounted with Slow Fade Gold anti-fade reagent with
DAPI nuclear counter stain (Invitrogen), then cover slipped using a number 1 ½ coverglass.
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4.1.3-Primary neuronal granule cell cultures

Twelve postnatal day 6 male rats were sacrificed and cerebellums were dissected away
from the rest of the brain under sterile conditions. Cerebellums were washed 3 xs with calciummagnesium free phosphate buffered saline (CMF-PBS). Samples were subjected to trypsinisation
and placed on a manual rotor for 5 minutes. Samples were washed again 3x with CFM-PBS then
treated with DNase and triturated sequentially 10xs with 3 pasture pipettes of decreasing size to
dissociate cerebellar granule cells. Samples were left to sit on ice and 2 minutes later the
supernatant was collected and transferred to a new tube. Samples were then centrifuged at 4°C
for 1,000 RPM for 5 minutes. DNase was then removed from the sample leaving only the pellet,
which was then resuspended in 1mL of Minimum Essential Medium (MEM) Eagles Serum.
Samples were triturated again in the same manner as before. A 1:10 dilution of sample into
MEM was used to count cells using a hemocytometer. Desired cell suspensions were calculated
using a dilution factor to yield 1.5x106 cells per poly-D-lysine coated cover slip in a 24 well
plate. The next day MEM was replaced with fresh MEM containing N2 supplement and cells
were treated with dose responses of PbCl- (i.e. 0.05μM, 0.1 μM, 0.5 μM, 1 μM, and 1.5 μM). The
following day (i.e. 3rd day in vitro) cells were fixed and subjected to IHC same as the procedures
above.

4.1.4- Confocal microscopy and Imaris image processing

Tissue were visualized under a Leica SP2 AOBS confocal microscope with a 40x oil
objective for brain slices and a 63x oil objective for primary neuronal granule cell cultures. Zstacks were taken of the sections and regions of interest. Images were then quantified using the
Imaris software (Bitplane, South Windsor CT) digital intensity mean analysis and reconstruction
of the sections. All settings were equivalent within comparative brain/granule cell culture regions
and standardized across samples and treatments.

4.1.5-Statistics

All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK). An Age X
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Treatment X Protein ANOVA was used to identify factor and interaction effects. Significant
differences were determined by either an equal or unequal N Tukey’s HSD post hoc comparisons
test. Significance levels were set at p < 0.05 with a SEM of 95%. Data are presented as mean ±
SEM.

4.2-Results

Figure 15. Pb2+ effects on KCC2 expression (Green) patterns in cortex as a function of age.

Figure 16. Pb2+ effects on KCC2 IHC mean intensity expression in cortex as a function of age.
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Figures 15-16 showed an Age effect (DF=3, MS=146,787, F=150.895, p<0.001***) and an Age
X Treatment interaction (DF=3, MS=78,563, F=80.762, p<0.001***).

Figure 17. Pb2+ effects on KCC2 expression (Green) patterns in dentate gyrus as a function of
age.

Figure 18. Pb2+ effects on KCC2 IHC mean intensity expression in dentate gyrus as a function
of age.

44

Figures 17-18 showed an Age effect (DF=3, MS=175,754, F=167.295, p<0.001***), a
Treatment effect (DF=1, MS=71,122, F=67.6999, p<0.001***), and an Age X Treatment
interaction (DF=3, MS=51,263, F=48.796, p<0.001***).

Figure 19. Pb2+ effects on KCC2 expression (Green) patterns in CA3 as a function of age.

Figure 20. Pb2+ effects on KCC2 IHC mean intensity expression in CA3 as a function of age.
Figures 19-20 showed an Age effect (DF=3, MS=29,660, F=22,621, p<0.001***), a
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Treatment effect (DF=1, MS=72,474, F=55,274, p<0.001***), and an Age X Treatment
interaction (DF=3, MS=37,357, F=28,491, p<0.001***).

Figure 21. PbCl- alters GABAAR expression (Green) in culture and VSCC-β3 nuclear
translocation (white arrow pointing to Red) in cerebellar granule cell cultured neurons.
(uppercase letter shows field and lower case letter shows magnified cell). Images were taken
with a 40x oil objective.
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Figure 22. PbCl- induces a curvilinear effect on VSCC-β3 nuclear expression in cerebellar
granule cell cultured neurons.
Figure 22. shows a curvilinear relationship between increased dose responses of PbCl- on
increasing VSCC-β3 nuclear expression at lower and decreased nuclear expression at higher
doses. PbCl- has a treatment and Dose effects as independent factors in a one way ANOVA
(DF=5, MS=413,913, F=105.44, p<0.001***) with an unequal Tukey post hoc analysis.
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Figure 23. PbCl- induces a curvilinear effect on GABAAR expression in cerebellar granule cell
cultured neurons.
Figure 23. shows a curvilinear relationship between increased dose responses of PbCl- on
GABAAR expression in cerebellar granule cell cultured neurons. PbCl- has a treatment and Dose
effects using a one way ANOVA (DF=5, MS=880,243, F=598.4, p<0.001***) with an unequal
Tukey post hoc analysis.
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Figure 24. PbCl- decreases KCC2 expression (Green) in cerebellar granule cell cultured neurons
regardless of dose (uppercase letter shows field and lower case letter shows magnified cell).
Images were taken with a 40x oil objective.
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Figure 25. PbCl- reduces KCC2 expression in cerebellar granule cell cultured neurons regardless
of dose.
Figure 25. shows a decreased KCC2 expression in cerebellar granule cell cultured
neurons in response to PbCl- regardless of dose. PbCl- has a Treatment and Dose effects using a
one way ANOVA (DF=5, MS=108,607, F=2,400.4 p<0.001***) with an unequal Tukey post hoc
analysis.

4.3-Discussion
Our data showed that in the gestational rat model Pb2+ toxicity prematurely shifted
KCC2 protein expression for PND 7 to PND 2 in cortex, DG, and CA3 regions of the
hippocampus evidenced by immunohistochemistry (Figures 15-20.). In addition, the normal
trajectory of KCC2 peak expression was observed at PND 14 in cortex, DG, and CA3 in control
rats (Figures 15-20.). Interestingly, in the cortex Pb2+ exposure reduced KCC2
immunoreactivity at PND14 and PND 22 when compared to controls (Figures 15-18.). In the
DG Pb2+ decreased KCC2 immunoreactivity at PND 14 and remained elevated in contrast to
controls at PND 22 (Figures 19-20.). These findings implicate that gestation Pb2+ exposure may
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prematurely increase expression of KCC2 resulting in a premature GABA-shift in early
development resulting in altered excitation-to-inhibition balancing and an inappropriately wired
brain.
In order to assess the exact effects on the VSCC-β3 and GABAAR expression as a
function of increased Pb2+ exposure we examined the dose response effects of PbCl- in primary
cerebellar granule cell cultured neurons 3 days in vitro (3 DIV). Our results showed that PbCl- at
low concentrations increases VSCC-β3 and at high concentrations reduced immunoreactivity
with peak expression at PbCl- 0.1µM in contrast to control conditions (Figures 21-23.). These
findings describe an atypical dose response curve where higher doses of PbCl- may appear to be
less detrimental, but result in irreparable neurotoxicity. Essentially, other neurobiological
factors, such as astroglia cells, may help compensate with mediating high doses of PbCl-,
whereas at low doses such compensation may not be possible.
Interestingly, the cerebellar granule cells GABAAR immunoreactivity showed similar
effects as did the VSCC-β3 (Figures 21-23.); however, peak expression of GABAAR was
observed at PbCl- 0.5µM. These findings showed that VSCC-β3 is more sensitive to PbCl- insult
and the early GABAergic system is altered suggesting interference with increased VSCC-β3 and
GABAAR synergistic activity at low and reduced synergistic activity with high doses of PbCl-.
When we applied the same dose response of PbCl- to the cerebellar granule cells we
observed a drastic decrease in KCC2 immunoreactivity (i.e. ~40-50%) irrespective of dose;
indicating that PbCl- produced delays in the GABA shift in isolated cultured neurons when
compared to control conditions (Figures 24-25.). These findings indicate that Pb2+ can interrupt
early GABAergic development through perturbing the precise interplay between the VSCC-β3
and GABAAR; thereby secondarily affecting KCC2 expression resulting altered excitation-toinhibition signals in the brain with altered neural networks.
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5.0 - Chronic gestational lead exposure enhances spontaneous and inhibits stimulationevoked release of glutamate analog, D-2, 3,-3H-aspartic acid from synaptosomes in early
cortical and post natal hippocampal development:

5.1-Methods

5.1.1-Subjects

Experimentally naïve male Long Evans Hooded rats (Taconic, N.J.) Rattus norvegicus
(Control n = 96; Pb2+ n = 96) were tested in accordance with The College of Staten Island
(CUNY) IACUC approval procedures. Long Evans male and female rats were paired. Rats were
fed as described in section 2.1.1. Age matched controls were used as a reference group. At
postnatal days (PND) 2, 7, 14 and 22 rats were selected from each treatment condition (i.e. n = 8)
for frontal cortex and hippocampal synaptosomal preparations to assess neurotransmitter release
properties and (i.e. n = 4) for both neurotransmitter uptake and binding studies respectively. To
assess chronic gestation Pb2+ effects as a function of brain injury and plasticity during early
development we selected the following time points to map a developmental trajectory: PND 2
during astrocyte proliferation, dendritic arborization, and gonadal hormones of immature neurons
prior to the critical period, PND 7 during the critical period including synapse formation and
spine growth, PND 14 post critical periods, and PND 22 as mature neurons (See Review Kolb
and Gibb, 2001).

5.1.2-Synaptosomal sample preparation
Long Evans Hooded rats at PND 2, 7, 14, and 22 were anesthetized with Nembutal® (i.p.
injection 50mg/Kg) and sacrificed in accordance with The College of Staten Island’s (CUNY)
IACUC policies and procedures. In two sets of experiments either frontal cortices or hippocampi
were dissected, extracted, weighed, and homogenized in a 1:10 dilution (w/v) buffer containing
0.32M sucrose, 1mM MgSO4, 20mM HEPES and pH adjusted to 7.4 with NaOH
(Sigma/Aldrich, MO). Samples were pestled in a glass homogenizer with 18 strokes, and 1ml of
the sample was collected into an eppendorf tube. The 1ml sample was then centrifuged at 5,000
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rpm x 10 minutes at 4°C (Beckman TL-100 Ultra Centrifuge, MD). The supernatant from the
sucrose gradient was collected and re-centrifugated at 19,000 rpm x 20 minutes at 4°C, while the
pellet was discarded. The subsequent pellet containing synaptosomes was re-suspended in 800µl
of oxygenated (O2 95%/CO2 5%) artificial cerebrospinal fluid (aCSF) solution containing
124mM NaCl, 2mM CaCl2, 4.5mM KCl, 1mM MgCl2, 26mM NaHCO3, 1.2mM NaH2PO4, and
10mM C6H12O6 with pH 7.4. (Sigma/Aldrich, MO) then centrifugated for 2 minutes at room
temperature (Beckman # 348750 Microfuge, CA). This step was repeated twice. The
synaptosomal pellet was then dissolved by pipette in 1ml oxygenated aCSF solution. Lastly,
200µl of the synaptosomes were used in the experiments that follow.

5.1.3-Synaptosomal spontaneous and evoked neurotransmitter release experiments
Synaptosomal neurotransmitter release samples (i.e. 200µl) were loaded into an
electrically inducible chamber (Brandel SF-12 Suprafusion System, MD) along with 3µl of
1mCi/mL D-2,3,3H-aspartic acid (ARC, Inc., MO); a non-metabolized glutamate analogue to
assess Glutamatergic synaptosomal excitability. Samples were incubated for 1 hour while being
temperature regulated at 37-39ºC. Perfusion flow rates were adjusted to 90% pumping rate
(2.25ml/min). After the incubation period, a 30 minute pre-collection period was done to wash
out excess background radioactivity that was not accumulated into the synaptosomes. The
experimental samples were collected every 2 minutes in individual scintillation vials. The first 9
scintillation vials were averaged and taken as a baseline measure of spontaneous release. Sample
10 was then electrically stimulated with a 10Hz, 10mA stimulus for 20 seconds (Brandel 12
channel electric stimulation unit, MD) and another 10 scintillation vials were collected post
stimulation. These remaining samples were taken as measurements of evoked release. Post
experiment, 3.4ml of ready safe scintillation cocktail liquid (Beckman Coulter™, CA) were
added to all collection vials capped and vortexed for 10 seconds. All scintillation vials were set
in trays for 24 hours. The following day scintillation counts per minute (CPM) were collected for
10 minutes per vial (Beckman Coulter™ LS 6500 Multipurpose Scintillation Counter, CA).

5.1.4-Synaptosomal neurotransmitter uptake experiments
Watman circle filter papers 24mm (GF/B Circles: Cat: 1821-024) were soaked for 1 hr in
a 0.1% poly ethyleneimine solution to create an adherent substrate to the filter for the
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synaptosomes used in both uptake and binding experiments. Filters were then left to air dry.
Once dry the filters were placed on the Hoefer Scientific Model # FH224V/FH225V 10 PLC
FLTR HLDR w/valves 25mm (San Francisco, CA) followed by installing the valve chambers
atop the filters. Each chamber was filled with 500µl of aCSF. A radioactive glutamate solution
was prepared with 2µl of stock D-2, 3,3H-aspartic acid (ARC, Inc., MO) and adjusted to 22ml
using the same aCSF solution as in the release studies. From this solution 1ml was added to each
chamber. Synaptosomal samples were prepared identical to the release studies except that the
synaptosomal pellet was dissolved with a 200µl pipette in 1ml of oxygenated aCSF solution.
Then 200µl of sample was added to each chamber (i.e. total volume 1.7ml) and left to incubate
for 2 minutes. After 2 minutes, each sample was vacuumed out and rinsed with 1mL of aCSF
then vacuumed 3 times. Samples were then left to air dry for 2 minutes and filter papers were
collected into scintillation vials and prepared identically for CPM determination as the release
samples.

5.1.5-Synaptosomal neurotransmitter binding experiments
Whatman circle filters were prepared identically to the uptake studies. Brain
homogenates from cortex and hippocampus were centrifuged at 3,400g X 20 minutes and
replaced with fresh binding buffer 4 times to wash out endogenous glutamate (i.e. 1-3μM) to
create glutamate free synaptosomal samples. Binding buffer comprised of: 30mM Tris-HCl,
2.5mM CaCl2, and pH 7.3 (Sigma-Aldrich, MO). From the synaptosomes two equal amounts of
200μl were placed into separate Eppendorf tubes (i.e. one for hot D-2, 3,3H-aspartic acid (ARC,
Inc., MO) and the other for cold glutamate) to assess total amount of binding hot glutamate vs.
hot + cold glutamate binding was determined via a subtraction method divided by the amount of
protein in the synaptosomal fraction. A 100mM glutamate (Sigma-Aldrich, MO) was made and
diluted to a 1mM glutamate solution and then a final concentration of 100μM glutamate. The
radioactive (i.e. hot) D-2, 3,3H-aspartic acid solution was made by taking 5μl of D-2, 3,3Haspartic acid and adding it to 5μl of 1mM cold glutamate. The cold glutamate sample contained
200μl of synaptosomes, 200μl of D-2, 3,3H-aspartic acid solution, 300μl of binding buffer and
80μl of 1mM cold glutamate. The hot glutamate sample contained 200μl of synaptosomes,
200μl of D-2, 3,3H-aspartic acid solution, 380μl of binding buffer. These samples were
incubated for 45 minutes at 37°C. Following incubation samples were immediately filtered and
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washed 3 times with binding buffer. Samples were then left to air dry for 2 minutes and filter
papers were collected into scintillation vials and prepared identically for CPM determination as
the release samples.

5.1.6-Synaptosomal protein determination procedures
The sample tubes from each of the experiments that were prepared for the synaptosomal,
uptake, and binding experiments were used to quantify the protein concentration (µg/µl) per 1:10
dilution of sample (mg/ml). Proteins were subjected to a Bradford assay using bovine serum as
the reference protein with a Bio-Rad DC Protein colorimetric assay kit (BIO-RAD 500-0116,
CA) according to manufacture guidelines. Briefly, standards of bovine serum were freshly made
using the following protein concentrations 0.0, 0.0125, 0.250, 0.5, 0.75, 1.0, 1.25, 1.5, and
2µg/µl respectively. Standards were run in triplicates simultaneously with unknown proteins
from the synaptosomal experiments. Using a 96 well plate, 5µl of standards and unknown
protein samples were added into each well, followed by 25µl of working reagent A+S, and
finally 200µl of reagent B were added (i.e. total volume 230µl/well). The plates were gently
agitated to mix the reagents and were stored in Napco Model 6300 (Surplus Solutions, LLC.,
MA) CO2 incubator for 30 minutes prior to being read at 750nm absorbance spectrum on a
Spectra Max 340PC microplate reader (Molecular Devices, CA). Protein absorbencies were read
and data computed using SoftMax Pro® data analysis software. A standard protein curve was
calculated using an average of the triplicate samples verses the unknown protein concentrations
(R2 > 0.9) as a function of protein concentration (µg/µl) against optical density absorbed from
the protein when read at 750nm.

5.1.7-Normalization of synaptosomal protein against CPM
Counts per minute (CPM) of D-2,3,3H-aspartic acid were recorded over a 10 minute
period per sample using a Beckman Coulter LS6500 Multipurpose Scintillation Counter
(Fullerton, CA). Obtained values for D-2,3,3H-aspartic acid CPM data were taken and divided by
the amount of protein from each respective 1ml sample. The resultant CPM/mg protein was
graphed as amount of basal uptake and spontaneous release rates of 3H-D-Aspartate prior to and
post electrical stimulation. Results from the release studies were normalized against the first 9
spontaneous baseline scintillation vials prior to electrical stimulation to determine the relative
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difference in D-2,3,3H-aspartic acid release from synaptosomes. In both cases Pb2+ exposed
samples were normalized against controls.
In the release studies the CPM/mg protein were collected from the 2 minute incubated
samples and Pb2+ exposed samples were normalized against controls. For the binding studies the
CPM/mg protein were collected from both the hot (i.e. D-2,3,3H-aspartic acid only) and cold
glutamate (i.e. D-2,3,3H-aspartic acid +100μM glutamate) samples to determine total binding by
subtracting the difference from a competitive binding from non-competitive binding.

5.1.8-Statistical analyses
All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK). For the
spontaneous and evoked release, uptake, binding, and Ca45 accumulation studies factorial
ANOVAs were used to assess Age, Treatment, and Age X Treatment interaction effects. For both
uptake and binding studies a factorial ANOVA was used to assess Age, Treatment, and Age X
Treatment interaction effects. Significance levels were set at α= 0.05% with a 95% ± SEM.
Significant differences were determined by equal and unequal Tukey’s HSD post hoc
comparisons test.
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5.2-Results

Figure 26. Effects of chronic gestational Pb2+ exposure on spontaneous 3H-D-Asparate release in
cortex (A) and hippocampus (B) as a function of age during early post natal development. Pb2+
increases spontaneous release at PND 2, 7, and 22 in cortex (A) and PND 14 in hippocampus
(B).
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Figure 26. in the cortex the spontaneous neurotransmitter release studies revealed an Age
effect (DF=3, F=40.906, p<0.001***), a Treatment effect (DF=1, F=32.74, p<0.001***), and an
Age X Treatment interaction (DF=3, F=17.36, p<0.001***) (A). Figure 26. in the hippocampus
the spontaneous neurotransmitter release studies showed an Age effect (DF=3, F=25.99,
p<0.001***) and an Age X Treatment interaction (DF=3, F= 6.63, p<0.001***) (B).
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Figure 27. Effects of chronic gestational Pb2+ exposure on evoked 3H-D-Asparate release in
cortex (A) and hippocampus (B) as a function of age during early post natal development. Pb2+
inhibits evoked neurotransmitter release at PND 2 and 7 in cortex (A) and PND 2-22 in
hippocampus (B).
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Figure 27. in the cortex the evoked release studies showed an Age effect (DF=3,
MS=11,415, F=6.62, p<0.001***), a Treatment effect (DF=1, MS=10,658, F=6.18, p<0.02**)
and an Age X Treatment interaction (DF=3, MS=9,239, F=5.36, p<0.001**) (A). Figure 27. in
the hippocampus the evoked release studies showed an Age effect (DF=3, MS=4,180, F=6.1,
p<0.001***) and a Treatment effect (DF= 1, MS=,, F=5.46, p<0.02*) (B).
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Figure 28. Effects of chronic gestational exposure of Pb2+ on 3H-D-Asparate uptake and binding
in cortex (A & B) and hippocampus (C& D) as a function of age during early post natal
development. Pb2+ decreases neurotransmitter uptake at PND2 and increases uptake at PND 7 in
cortex (A). In hippocampus uptake is increased at PND 22 (B). In cortex Pb2+ increases
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neurotransmitter binding at PND 2, 14, and 22, but reduces it at PND 7 (C). In hippocampus
Pb2+ follows the same trajectory, but with a less pronounced effect at PND 7 and with enhanced
effects at PND 14 and 22 (D).
Figure 28. in the cortex the uptake studies showed an Age effect (DF=3, MS=1,419.91,
F=40.58, p<0.001***), a Treatment effect (DF=1, MS=189.69, F=5.42, p<0.05**) and an Age X
Treatment interactions (DF=3, MS=603.74, F=17.25, p<0.001***) (A). Figure 28. in the
hippocampus the uptake studies revealed an Age effect (DF=3, MS=13,319.4, F=21.41,
p<0.001***), a Treatment effects (DF=1, MS=2,086.28, F=33.85, p<0.001***) and an Age X
Treatment interaction (DF=3, MS=1,630, F=26.45, p<0.001***) (B).

Figure 28. in the cortex the binding studies showed an Age Effect (DF=3, MS= 748,317,
F=29.48, p<0.001***) and an Age X Treatment interaction (DF=3, MS=192,600, F=7.59,
p<0.001***) (C). Figure 28. in the hippocampus the binding revealed an Age effect (DF=3,
MS=1,658,008, F=73.66, p<0.001***), a Treatment effect (DF=1, MS=398,405, F=17.72,
p<0.001***) and an Age X Treatment interaction (DF=3, MS=122,675, F=5.46, p<0.01**) (D).
5.3-Discussion
In the spontaneous vs. evoked 3H-D-Asparate experiment, chronic gestational Pb2+
exposure induced early developmental changes in synaptosomal physiology at select age points
between the cortex and hippocampus (Figure 26-A&B.). In the cortex, Pb2+ enhanced
spontaneous release of 3H-D-Asparte at PND 2 and 22 when compared with controls (Figure 26A.). In addition, Pb2+ exhibited a significant increase in spontaneous neurotransmitter release at
PND 2 followed by a delayed and gradual recovery with elevations at PND 22 (Figure 26-A.).
Peak spontaneous neurotransmitter release in the cortex was observed in PND 14 in controls,
whereas it was observed at PND 2 in Pb2+ treated rats (Figure 26-A.). Interestingly, in the
hippocampus, Pb2+ treatment only exhibited a reduction in spontaneous release at PND 14
(Figure 26-B.). The peak ages of hippocampal spontaneous release was observed at PND 2 and
14 in controls, with Pb2+ treatment showing a consistent pattern of early elevations in
spontaneous neurotransmitter release followed by a delayed and gradual recovery by PND 22
(Figure 26-B.). In contrast to spontaneous neurotransmitter release, in the cortex, Pb2+ reduced
evoked neurotransmitter release at PND 2 and 7 followed by benign effects at PND 14 and 22
(Figure 27-A.). In hippocampus Pb2+ reduced evoked neurotransmitter release consistently at
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PND 7, 14, and 22 as a function of age (Figure 27-B). This indicates that the cortex is most
vulnerable to Pb2+ disruption in neurotransmission at PND 2 and 7, whereas the hippocampus is
vulnerable at later developmental ages (i.e. PND 7, 14, and 22) (Figure 27-A&B).
In the cortex Pb2+ reduced uptake at PND 2 and increased uptake at PND 7 when
compared to controls (Figure 28-A). Peak cortical uptake in controls was observed at PND 7 and
was significantly greater in Pb2+ treated rats at this age. In contrast, in hippocampus Pb2+
treatment resulted in reduced uptake at PND 7 and increased uptake at PND 14 and 22 when
compared to controls (Figure 28-B). Peak uptake hippocampal uptake in controls was observed
at PND 14 and was significantly greater at PND 22 in Pb2+ treated rats.
In cortex peak binding was observed at PND 7 in both treatment groups. Notably, Pb2+
treatment increased binding at PND 2, 14, and 22, while at PND 7 resulted in a decrease in
binding (Figure 28-C). Pb2+ significantly reduced PND 7 binding and increased PND14 binding
evidencing a shift in post synaptic communication consistent with developmental delays. The
same binding effects in response to Pb2+ were observed in hippocampi, with the exception that at
PND 7 no Pb2+ effects were noted (Figure 28-D).
We evaluated gestational Pb2+ effects on cortical and hippocampal synaptosomal
spontaneous and evoked release, uptake, and binding of glutamate analog, D-2,3,-3H-aspartic
acid which we considered as indicative of changes at Glutamatergic synapses. D-2,3,-3H-aspartic
acid was selected as a reliable determinant of neurotransmitter properties given that it is not
metabolized through the glutamate/glutamine/GABA-cycle. In addition, changes observed in
neurotransmitter properties were due to altered gene and protein expression as a result of chronic
Pb2+ insult, rather than an acute in-vitro test solution application. Interestingly, these lifelong
changes in neurotransmitter properties by Pb2+ produced results consistent with the biphasic
properties reported in the literature in-vitro.
These experiments evidence the three major aspects of neurotransmission: 1) release, 2)
uptake, and 3) binding of postsynaptic targets. Pb2+ disrupts the efficiency on synaptosomal
vesicular accumulation of glutamate resulting in increased extracellular glutamate with the
potential for excitotoxicity, increased glial cells clearing away excess transmitters from the
synaptic cleft and increased transporter activity to maintain appropriate signaling. Since Pb2+
causes synaptic vesicles to accumulate less neurotransmitter at PND 2 and more at PND 7 in
cortex it will result in reduced glutamate recycling and subsequent release. Pb2+ increases
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spontaneous release of neurotransmitters suggesting altered non-specific transmitter signals
producing outcomes consistent with altered synaptogenesis in early development. Pb2+ also
showed an increase in binding at PND 2, 14, and 22 indicating increased glutamate post synaptic
receptors and sensitivity to glutamate which may be a compensatory mechanism for a reduced
number of post synaptic contacts if Pb2+ resulted in reduced neuronal survival during
development. Increasing glutamate post synaptic receptor expression would increase the
probability of neuron survival in response to Pb2+ insult developmentally. In addition, between
PND 7-14 there is much brain plasticity to compensate for injuries and enduring insults prior to
or after this critical window will reduce long term outcomes associated with this neurotoxicant
injury.
Pb2+ enhanced spontaneous release at PND 2 in the cortex, whereas in hippocampus at
PND 14 release was inhibited. Evoked release was inhibited at PND 2 and 7 in cortex and trends
of inhibition were evident at PND 7, 14, and 22 in hippocampi. These data show Pb2+-induced
cortical aberrations at PND 7 and at PND 14 in hippocampi. Pb2+ reduced cortical uptake at
PND 2 and increased at PND 7. In contrast, uptake was enhanced at PND 22 in hippocampi. At
PND 7 there was reduced binding in cortex, whereas at PND 14 binding was increased in
hippocampi. We suggest that gestational Pb2+ exposure causes imprecision of cortical and
hippocampal signal-mediated pruning post natally which may obscure relevant signals while
increasing non-specific background activity resulting in improper network connections
throughout development.
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6.0-Neurobehavioral effects of chronic gestational Pb2+ exposure: Taurine as a
neuroprotective agent to recover these GABAergic learning deficits

6.1-Methods

6.1.1-Subjects

Long Evans male and female rats were paired. Rats were fed as described in section 2.1.1
ad libitium from pairing, throughout gestation, and continued through parturition and weaning.
At postnatal day (PND) one set of 22 rats were assigned to behavioral assays as follows: Open
Field (OF), Elevated Plus Maze (EPM), Light/Dark Test (LD). Also, independent sets of rats
were assigned to the Hole Board Test (HB), Context Fear Conditioning Test (CFC) and Auditory
Cued Fear Conditioning Test (ACFC), and the Acoustic Startle Response (ASR) with pre-pulse
inhibition (PPI) test to control for carryover effects and to ensure novelty. Rats were
administered taurine, a GABAAR agonist, 43mg/Kg i.p. injection 15 minutes prior to behavioral
testing to assess taurine's influences on GABAergic behavioral regulation in reducing anxiety,
irritability, stress and increasing inhibitory learning and memory.

6.1.2-Open field
At PND 22 rats were examined during 10 minutes of locomotor exploration in the Open
Field test (OF) (376mm H x 914mm W x 615mm L) in an illuminated room 300 Lux. This test
was used to evaluate if there were any locomotor problems and or anxiety issues in the rats
behaviors. Locomotor variables including time mobile (s) in zone and latency for first exit from
zone (s) were recorded and post analyzed using the Anymaze® video tracking software
transmitted via a ceiling mounted SONY-Handy Camera ran to a standard HP 1.6GHz computer.

6.1.3-Elevated plus maze

At PND 23 rats were examined during 10 minutes of anxiety testing in the Elevated Plus
Maze (EPM) (159mm H x 70mm W x 730mm L) in an illuminated room 300 Lux. This tests
evaluates anxiety phenotypes. Locomotor variables including time mobile (s) in zone, number of
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zone entries, time head dipping over open arm ledge, and number of head dips over open arm
ledge were recorded and post analyzed using the Anymaze® video tracking software transmitted
via a ceiling mounted SONY-Handy Camera ran to a standard HP 1.6GHz computer.

6.1.4-Light/dark test

At PND 24 rats were examined during 10 minutes of anxiety testing in the Light/Dark
test (LD) (50mm H x 150mm W x 300mm L) in an illuminated room 300 Lux. This test uses
intrinsic motivation (dark escape) as an anxiety test. Locomotor variables including time in zone
and time immobile (s) in zone were recorded and post analyzed using the Anymaze® video
tracking software transmitted via a ceiling mounted SONY-Handy Camera ran to a standard HP
1.6GHz computer.

6.1.5-Hole board test

At PND 30-40 rats were examined during 10 minutes of anxiety testing in the Hole Board
test (HB) (610mm H x 610mm W x 610mm L) in an illuminated room 300 Lux on day 1. This
test is a neurotoxicity test that evaluates fear and cognitive behaviors. On day two rats were
tested in the same chamber and lighting, but 4 olfactory gradients (i.e. vanilla, orange, lemon,
and almond) were placed in petri dishes below the four corners of the HB test to promote
exploratory movement. Locomotor variables including time freezing (s) time exploring (s)in
zone, number of head pokes, latency to first head poke, and time head poking were recorded and
post analyzed using the Anymaze® video tracking software transmitted via a ceiling mounted
SONY-Handy Camera ran to a standard HP 1.6GHz computer.

6.1.6-Contextual fear conditioning
At PND 24-30 behaviorally naive rats were transferred to the testing room and remained
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red
ambient light. After the acclimation to the testing room rats were gently picked up and placed
into the context fear conditioning chamber (Med Associates) (215.9mm H x 260.35mm W x
254mm L). This test evaluates fear induced learning and memory. The testing paradigm was as
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follows: (a) Day 1 acquisition phase: 120s acclimation, 10s later sound was emitted for 30s
duration, after 10s of the sound presented a light was illuminated for 10s and during the last 2s of
the sound a 0.5mA shock was given for 5s in duration as the conditioned aversive stimulus.
Following the delivery of the shock the rats latency to break 3 infrared beams were measured
every 10s for 60s followed by a 70s inter-trial-interval. Three trials were presented during day 1
which was considered the learning acquisition phase. (b) Day 2 retention phase: The exact same
testing procedures were administered as in day 1 except that there was no shock delivered.
6.1.7-Auditory cued conditioning
At PND 24-30 behaviorally naive rats were transferred to the testing room and remained
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red
ambient light. After the acclimation to the testing room rats were gently picked up and placed
into the context fear conditioning chamber (Med Associates). This test used sound stimuli paired
with environmental context to evaluate learning and memory. The testing paradigm was the same
as the CFC test except that on Day 3 rats were place in an altered context. The chamber was the
same size, but was divided diagonally with a black plexiglass (349.25mm) and the floor coated
with a black rubber mat. On the opposite of the plexiglass where the rats could not access a Petri
dish was filled with a vanilla extract to stimulate movement in the altered context chamber.
Motion was recorded for a single trial with a baseline measure for 180 seconds followed by the
onset of the same auditory cue used in the CFC training during the prior two days. However, the
tone lasted 180 seconds.
6.1.8-Acoustic startle response habituation
At PND 30-46 behaviorally naive rats were transferred to the testing room and remained
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red
ambient light. After the acclimation to the testing room rats were gently picked up and placed
into the acoustic startle response chamber MED-ASR-Pro1 (Med Associates Inc., VA) for the
length of the testing session (i.e. 30 minutes). This test evaluates habituation learning to repeated
exposer to auditory stimuli. All subjects were administered a one block design consisting of 20
trials with 115 decibels (dB) with inter-trial-interval (ITI) of 15 ms to assess startle habituation.
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6.1.9-Acoustic startle response and pre-pulse inhibition
At PND 30-46 behaviorally naive rats were transferred to the testing room and remained
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red
ambient light. After the acclimation to the testing room rats were gently picked up and placed
into the acoustic startle response chamber MED-ASR-Pro1 (Med Associates Inc., VA) for the
length of the testing session (i.e. 30 minutes). This test evaluates the rats ability to reduce a
startling reflex in response to a lower sound preceding a loud sound. All subjects were
administered a three block design to assess pre-pulse inhibition learning. Block one consisted of
4 trials with a startle stimuli of 115 dB. Block two contained a random matrix of 16 trials with
unpredictable prepulses of 75dB, 85dB, 95dB, and 105dB with an ITI of 15 ms. Block three was
identical to block one. Data were driven via the motion sensor transducer platform and
transmitted to a standard desktop computer to analyze the data with the supplied Med Associated
Software.

6.1.10-Statistical analyses
All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK). Factorial ANOVAs
were used to assess Age, Treatment, and Age X Treatment interaction effects. Significance levels
were set at α= 0.05% with a 95% ± SEM. Significant differences were determined by equal and
unequal Tukey’s HSD post hoc comparisons test.
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6.2-Results

Figure 29. Pb2+ increased anxiety measures in OF and taurine reduced anxiety through
GABAergic modulation in latency to exit center zone (A) and time mobile in center zone (B).
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Figure 29. The OF test for center zone exploration latency revealed a Tau Treatment
effect (DF=1, MS=14,459.5, F=8.97, p<0.004**) (A). Figure 29. In the OF the time mobile
showed Pb2+ effect (DF=1, MS=895.92, F=4.08, p<0.05*) and a Tau Treatment effect (DF=1,
MS= 2,348.56, F=10.7, p<0.001***) (B).
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Figure 30. Pb2+ showed no difference on EPM anxiety measures, but taurine decreased anxiety
in control rats and increased anxiety in Pb2+ treated rats (A&B).
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Figure 30. The EPM test for time mobile in zone showed a Taurine effect (DF=1, MS=
7,946.6, F=6.32, p<0.01 **), a Zone effect (DF=2, MS=49,216.2, F=39.12, p<0.001***) and a
Pb2+ X Taurine interaction (DF=1, MS=6,158.3, F=4.9, p<0.03*) (A). Figure 30. The EPM test
for number of zone entries revealed a Pb2+ effect (DF=1, MS=642.14, F=6.86, p<0.01**), a
Taurine effect (DF=1, MS=1,138.62, F=12.16, p<0.001***), a Zone effect (DF=2,
MS=2,389.47, F=25.51, p<0.001***) and a Pb2+ X Taurine interaction (DF=1. MS=571.03,
F=6.09, 0.01**) (B).
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Figure 31. Taurine treatment increased anxiety in Pb2+ rats evidenced by reduced time head
dipping over the open arm ledge (A) but showed no difference in total number of head dips in the
EPM (B). Figure 31. The EPM time head dipping over the open arm ledge showed a Pb2+effect
(DF=1, MS=116.21, F=4.93, p<0.03*) (A). Figure 31. Revealed no significant differences (B).
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Figure 32. Taurine treatment increased anxiety in Pb2+ rats evidenced by increased acclimation
time in light chamber during the first minutes in Pb2+ rats and for first 5 minutes in Pb2+ &
Taurine rats in the LD test (A). However, this time spent in the light chamber was time spent
freezing rather than exploring the chamber (B).
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Figure 32. The LD test time in light chamber showed a Pb2+ effect (DF=1,
MS=4,196.16, F=25.80, p<0.001***), a Taurine effect (DF=1, MS=3,538.16, F=21.75, p<0.001)
and a Pb2+ X Taurine interaction (DF=1, MS=3,866.57, F=23.77, p<0.001***) (A). Figure 32.
The LD test time in light chamber immobile revealed a Pb2+ effect (DF=1, MS=2,349.13,
F=19.73, p<0.001***), a Taurine effect (DF=1, MS=1,812.86, F=15.23, p<0.001***) and a Pb2+
X Taurine interaction (DF=1, MS=2,419.16, F=20.32, p<0.001***) (B).
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Figure 33. Frequency comparisons between the traditional HB test for anxiety escape behaviors
(A) vs. a novel exploration test (B). The HB test showed a zone effect in which Pb2+ rats had
reduced head pokes in the center zone, but this trait improved with taurine treatment (A).
However, the day two’s testing procedures were more sensitive to assess neurotoxic behavioral
signatures, evidencing reduced number of head pokes in both zones in Pb2+ rats and with
recovery under taurine treatment (B).
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Figure 33. We used a traditional escape response HB test along with a novel exploration
HB test to tease apart the anxiety with the cognitive searching responses associated with total
number of head pokes in this test. The escape response HB test (A) evidenced a Zone effect
(DF=1, MS=1,392.56, F=13.1, p<0.001***). In contrast, the novel exploration HB test (B)
revealed a Zone effect (DF=1, MS=925.25, F=23.22, p<0.001***), a Pb2+ effect (DF=1.
MS=3,346.05, F=83.97, p<0.001***), a Zone X Pb2+ interaction (DF=1, MS=206.17, F=5.17,
p<0.03*) and a Pb2+ X Taurine interaction (DF=1, MS=188.93, F=4.74, p<0.03*).
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Figure 34. Latency to first head poke comparisons between the traditional HB test for anxiety
escape behaviors (A) vs. a novel exploration test (B). The HB test showed a zone and Pb2+ effect
in the escape condition, with no taurine differences noted (A). However, the day two’s testing
procedures were again more sensitive to assess neurotoxic behavioral signatures, evidencing
increased latency to first head poke by Pb2+ rats in the center zone and with recovery under
taurine treatment (B).
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Figure 34. We assessed the differences in latency for first head poke between these two
test conditions. The escape HB test (A) showed a Zone effect (DF=1, MS=10,976.8, F=11.53,
p<0.001***) and a Pb2+ effect (DF=1, MS=6,935.9, F=7.2873, p<0.009084**). The exploration
HB test (B) revealed a Zone effect (DF=1, MS=135,108.2, F=32.02, p<0.001***), a Pb2+ effect
(DF=1, MS=41,485.2, F=9.83, p<0.003**), a Zone X Taurine interaction (DF=1, MS=22,882.2,
F=5.42, p<0.02*) and a Zone X Pb2+ X Taurine interaction (DF=1, MS=18, 395.4, F=4.36,
p<0.04*).
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Figure 35. Time comparisons between freezing and exploring behaviors (A) and total time
engaged in hole poking behaviors during these test conditions (B). The HB test showed a Pb2+
and a taurine effect in which Pb2+ rats had increased time freezing in the escape condition and
decreased time freezing in the exploration condition (A); notably, taurine recovered the behavior
in the exploration condition (A). Interestingly, when comparing the time spent hole poking no
Pb2+ or taurine differences were noted in the escape conditions (B). Interestingly, Pb2+ rats
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showed a significant reduction in the exploration condition and taurine improved these behaviors
treatment (B).
Figure 35. We evaluated the differences in time freezing vs. exploring and total time
spent hold poking in each HB test condition. The behavioral engagement time comparisons
between tests (A) showed a Condition effect (DF=1, MS=1,061,194, F=221.88, p<0.001***), a
Pb2+ effect (DF=1, MS=29,813, F=6.23, p<0.01**), a Condition X Pb2+ interaction (DF=1,
MS=213,911, F=44.73, p<0.001***), a Condition X Taurine interaction (DF=1, MS=51,794,
F=10.83, p<0.001***) and a Condition X Pb2+ X Taurine interaction (DF=1, MS=59,831,
F=12.51, p<0.001***). The comparisons for time spent head poking between tests (B) revealed a
Condition effect (DF=1, MS=11,918.4, F=26.78, p<0.001***), a Pb2+ effect (DF=1, MS=14,
878.9, F=33.44, p<0.001***) and a Condition X Pb2+ interaction (DF=1, MS=2,241.7, F=5.04,
p<0.03*).
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Figure 36. Differences in Context Fear acquisition and extinction learning with respect to
context (A) and aversive stimuli (B). Pb2+ treated rats show no differences in fear learning, but
have reduced memory consolidation of the prior days learning as evidenced by extinction trials
in both context (A) and aversive (B) conditions. In addition, Pb2+ treated rats were more sensitive
to aversive conditioning than controls, which may have attributed to poor working memory
consolidation during training trials (B).
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Figure 36. In the CFC context learning revealed in the extinction condition a Pb2+ effect
(DF=1, F=21.74, p<0.001***) (A). Figure 34. In the CFC aversive learning showed in the
acquisition trials a Trial X Pb2+ interaction (DF=3, F=5.14, p <0.001**), and in the extinction
trials a Pb2+ effect (DF=1, F=48.89, p< 0.001***) (B).
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Figure 37. Differences in ACFC acquisition and retention learning with respect to context (A)
and aversive stimuli (B). Pb2+ treated rats showed reduced context learning (A), and initial
sensitization to aversive fear learning indicating stressful conditions that may impeded memory
consolidation of the prior days learning as evidenced by retention and altered context trials in
both context (A) and aversive (B) conditions.
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Figure 37. In the ACFC test during the context condition showed a Pb2+ effect (DF=1,
F=29.03, p<0.001***), a Trial effect (DF=3, F=173.794, p<0.001***) and a Pb2+ X Trial
interaction (DF=3, F=10.09, p<0.001***) (A). In the AFCF aversive stimulus condition revealed
a Pb2+ X Trial interaction (DF=5, F=2.73, p<0.05*) and a Trial effect (DF=5, F=75.718,
p<0.001***) (B).

Figure 38. Differences in Auditory Cued Context Conditioning and generalization into alternate
contexts. Pb2+ treated rats showed reduced freezing in an altered context when compared to
controls. However, once the tone previously paired with aversive foot shock was presented both
control and Pb2+ rats froze equivocally. This suggests that Pb2+ rats may be hyper excitable and
respond to new environments with increased stress.
Figure 38. In the ACFC test revealed a Condition effect (DF=1, MS=18,644,039,
F=335.41, p<0.001***) and a Pb2Effect (DF=1, MS=1,265,333, F= 22.76, p<0.001***).
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Figure 39. Effects of Pb2+ on non-associative startle habituation (A) and the effects of Pb2+
treated rats PPI learning through a pre-post startle 115dB intervention and the use of taurine (B).
The graph illustrates that Pb2+ rats are hypersensitive to auditory stimuli and they have delays in
habituation to non-associative stimuli (A). In addition, Pb2+ rats have disruptions in PPI learning
ability, but recover with taurine treatment. This suggests that taurine may recover GABAergic
learning and memory impairments induced by Pb2+ neurotoxicity during development.
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Figure 39. The startle non-associative habituation test showed a Trial effects (DF=19,
MS=424,655, F=2.47, p<0.001***) and a Pb2+ effect (DF=1, MS=11,108,541, F=64.52,
p<0.001***) (A). Figure 39. The startle PPI pre and post test comparisons revealed a Condition
effect (DF=1, MS=125,668, F=130.39, p<0.001***), a Taurine effect (DF=1, MS=22,432,
F=23.28, p<0.001***), a Condition X Taurine interaction (DF=1, MS=5,777, F=6.0, p<0.01**),
a Pb2+ X Taurine interaction (DF=1, MS=8,193, F=8,50, p<0.01**) and a Condition X Pb2+ X
Taurine interaction (DF=1, MS=10,982, F=11.4, p<0.001***) (B).

Figure 40. Effects of Pb2+ treated rats PPI learning through a pre-post startle 115dB intervention
and the use of Baclofen.
Figure 40. There was no Pb2+ or Baclofen treatment differences observed. However, there was
only a Condition Effect (DF=1, MS=148,161, F=121.72, p<0.001***).
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6.3-Discussion

The toxic effects of Pb2+ on the developing rat nervous system has been investigated to
assess early developmental GABAergic disruption and its implications with altering inhibitory
learning and memory. This goal was achieved using a multi-systems approach: blood lead levels
(clinical physiology), qRT-PCR (molecular genetics), brain and primary neuronal culture
immunology (immunohistochemical and cellular approaches), physiological cellular components
(synaptosomes and protein expression) and finally through learning and memory assessment
with GABA mimetic drug manipulations in the intact animal (behavioral pharmacology).
The influence of a 956ppm Pb2+ gestational diet (i.e. from birth to sacrifice) resulted in
pup mean blood lead levels (BLLs measured in μg/dL) at PND 2= 41.83 SEM± 14.17, PND 7=
34 SEM± 10.4, PND 14= 30.17 SEM± 7.77 and PND 22= 38.67 SEM±10.67. The dams at
corresponding Pb2+ exposure times evinced mean BLLs at PND 2= 37 SEM± 9, PND 7= 41.33
SEM± 21.33, PND 14= 39.33 SEM± 60.33 and PND 22= 43.6 SEM± 22.3 respectively. In
contrast, control pups and dams were Pb2+ negative. These ages were selected to determine
neurodevelopmental trajectories of the GABA-shift from excitation-to-inhibition postnatally in
our model.
We assessed the changes in GABAergic developmental regulatory mRNA gene
expression of Caβ3, GABAAR-β3, NKCC1, KCC2, GAD 80, 86, 65, and 67 in response to Pb2+
in the cortex and hippocampus at the aforementioned ages. Our results indicate a Pb2+ induced up
regulation of Caβ3 mRNA at PND 7 followed by a steady down regulation at PND 14 and 22. In
hippocampus, Caβ3 mRNA was down regulated at PND 7 and 22. This suggests Pb2+ inhibits
Caβ3 gene regulation in both brain regions beginning at PND 7.
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Notably, the GABAAR-β3mRNA expression was slightly down regulated in cortex at
PND 22, but was significantly down regulated in hippocampus at PND 7 and 22. This implicates
that the hippocampus is more vulnerable to Pb2+ alterations in GABAergic gene expression
suggesting interruption of inhibitory regulated learning and memory.
In cortex, NKCC1 mRNA was slightly up regulated at PND 2 and 7 in cortex, whereas in
hippocampus it was up regulated at PND 2 and down regulated at PND 7 as a consequence of
Pb2+. This suggests a Pb2+ specific divergent effect in cortex and hippocampus at PND 7 with
early Cl- importers increasing hyper polarization in both cortex and hippocampus at PND 2.
Notably, at PND 7 Pb2+ increased hyper polarization would occur due to increased NKCC1
expression whereas, in hippocampus decreased NKCC1 mRNA expression would result in
increased depolarization producing premature early brain excitability.
In contrast, KCC2 mRNA was up regulated at PND 2 and down regulated at PND 7 and
14 in cortex; whereas in hippocampus it was only down regulated at PND 2 and 7 then up
regulated at PND 14 in response to Pb2+. This suggests that in cortex Pb2+ prematurely switches
earlier than expected at PND 2 and is delayed until PND 22. In hippocampus KCC2 mRNA is
reduced at PND 2-7 and over expression is observed as a compensatory consequence for early
delay in this key GABAergic regulatory protein; resulting in increased Cl- extrusion from the
transporters and subsequently increasing depolarization. These premature delays and abnormal
early expression of cotransporters indicate a disruption in the expression of the GABAergic
networks in response to gestational Pb2+ exposure producing an organism with decreased
inhibitory regulation and increased susceptibility to brain excitability.
To determine more closely how and when these GABAergic networks are most
susceptible to Pb2+ perturbations we examined the expression of GAD enzymes as they are
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precursors for synthesizing early excitatory GABA (i.e. GAD 80 and 86) and late inhibitory
GABA (GAD 65 and 67). In cortex, early excitatory GAD80 and 86 mRNA were both up
regulated at PND 2 and 14 in response to Pb2+ indicating lasting expression of gestational
profiles that should not be present at the observed levels in postnatal life; thus, indicating an
altered GABAergic system with persistent excitation. The same observation was noted in
hippocampus, however GAD 80 was significantly down regulated at PND 2 as a consequence of
Pb2+.
Moreover, late inhibitory GAD 65 was slightly up regulated in cortex (i.e. increased
inhibition) and down regulated in hippocampus (i.e. decreased inhibition) at PND 7; whereas
GAD 67 was significantly down regulated at PND 22 in both cortex and hippocampus (i.e.
decreased inhibition) suggesting an altered influence in regulating GABA-dependent learning
and memory and increased susceptibility to brain excitability.
We also assessed MECP2 and FMR1 mRNA to determine whether or not we could
indicate select alteration in presynaptic vesicular release and postsynaptic plasticity based on our
previous findings suggesting altered GABAergic networks. In cortex MECP2 mRNA was up
regulated at PND 14 (i.e. increasing neurotransmitter release); whereas in hippocampus it was
down regulated at PND 22 (i.e. decreasing neurotransmitter release) in response to Pb2+.
Interestingly, we observed FRM1 mRNA down regulation (i.e. reduced postsynaptic plasticity)
at PND 14. Together these results indicate that Pb2+ induces brain region specific effects with
different trajectories and some delays in brain wiring and/or maturation that may require further
evaluation at a physiological level to elucidate how Pb2+ alters signaling based on these
molecular changes.
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Following these qRT-PCR findings we evaluated whether Pb2+ delays the spatialtemporal distribution (i.e. the pattern and age of onset) of developmentally regulated KCC2
expression in the cortex and hippocampus as a function of age. We observed that in cortex Pb 2+
increases KCC2 expression at PND 2 and decreases its expression at PND 14 and 22. This
suggests an early inhibition of GABA in the early postnatal cortex in response to Pb2+ and a
decreased inhibition of GABA in adolescence and adult rat brains; consistent with the late brain
being susceptible to excitability.
In hippocampus DG region KCC2 expression was increased at PND 2, 7 and 22; whereas
it was decreased at PND 14. Moreover, in hippocampus CA3 region KCC2 expression was
increased at PND 2, 7 and14 then decreased at PND 22 in response to Pb2+. This suggests that
the DG is more susceptible to brain excitability at PND 14; whereas, the CA3 region is more
susceptible to brain excitability at PND 22. Thus, further suggesting that Pb 2+ induces brain
region specific alterations between cortex and hippocampus and inter region changes within the
hippocampus in response to Pb2+.
We next evaluated in primary neuronal cerebellar cultures harvested from PND 5-7 rats
and treated 3 days in-vitro (3-DIV) with dose responses of PbCl-, whether or not Pb2+ can induce
VSCC-β3 nuclear translocation consistent with our hypothesis indicating the mechanism by
which Pb2+ would alter GABAergic synergistic signaling via the GABAAR and the VSCCs.
Results show that cultured neurons treated with PbCl- at 0.05μM, 0.1μM and 0.5μM produced an
increase in immunodetection of VSCC-β3 nuclear expression; whereas at exposures exceeding
these levels produced negligible nuclear expression when compared to control conditions.
Moreover, these data suggest that cultured neurons are more sensitive to low dose Pb2+ exposure
and as these levels increase neurons may appear to be insensitive, but more practically
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mechanisms involved in clearing/removing Pb2+ may have been saturated becoming essentially
inactivated at higher concentrations of exposure. This may produce more latent effects that can
further produce neuronal excitability and surrounding glial cell death if exposures remain chronic
resulting in irreparable neurotoxicity.
When cultured neurons were exposed to increasing dose responses of PbCl- GABAAR-β3
expression was increased at 0.05μM, 0.1μM, 0.5μM and 1μM; whereas at 1.5μM this expression
was decreased. This suggests that Pb2+ influences the increased expression of GABAARs to most
likely compensate for the increased neuron excitability produced by Pb2+. In addition, this
increased excitability produces synergistic effects with VSCCs having increased sensitivity to
low doses of Pb2+, which may act together as a mechanism perturbing early GABAergic
networks in the developing brain consistent with our hypothesis.
We also assessed the effects of PbCl- on KCC2 expression in cultured neurons. Results
show that KCC2 expression in cultured neurons are inhibited nearly 50% from control conditions
irrespective of PbCl- dose. Interestingly, this data is in opposition to what we have shown from
brain slice immunohistochemistry indicating that there may be some undetermined compensatory
mechanism preventing the intact brain from exhibiting conditions shown in culture due to
isolated in-vitro conditions.
We return our discussion to whether Pb2+ interferes with physiological functions at these
respective ages. To address this question we evaluated the spontaneous and evoked release of
glutamate analog, 3H-D-Asparate, its binding and uptake in synaptosomal tissue fractions from
cortex and hippocampus to assess neuronal communication in response to Pb2+. Results showed
that in cortex Pb2+ increased 3H-D-Asparate spontaneous release at PND 2, 7 and 22 and was
reduced at PND 14. In contrast, in hippocampus 3H-D-Asparate spontaneous release was slightly
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increased at PND 7 and decreased at PND 14. Comparatively, 3H-D-Asparate evoked release in
the cortex diminished at PND 2 and 7; whereas in hippocampus showed a trend of decreased 3 HD-Asparate evoked release from PND 7, 14 and 22.
In addition, in cortex uptake was reduced at PND 2 and increased at PND 7; whereas in
hippocampus 3H-D-Asparate uptake was reduced at PND 7 and increased at PND 14 and 22.
Lastly, in both cortex and hippocampus 3H-D-Asparate binding was increased at PND 2, 14 and
22, but decreased at PND 7. Taken together these data suggest that the synaptic turnover of
glutamate investigated on the synaptosomal fraction has been significantly modulated by Pb 2+
exposure.
The spontaneous release was increased at early time points with brain region selective
differences and evoked release was in opposite directions of these findings; evidencing a
biphasic response of Pb2+ having altered the synaptic proteins involved in neurotransmission
from development rather than being added in-vitro to the synaptosomal fraction preparations.
Additionally, in agreement with the previous observations of brain excitability the intensity of
glutamate uptake was observed to change in the following way: 1) due to increased spontaneous
release by Pb2+, synaptosomal fractions had difficulty accumulating Pb2+, 2) this diminished
accumulation resulted in decreased evoked release, 3) there was a significant selectively decrease
in uptake at PND 2 and increased uptake at PND 7 in cortex; whereas at PND 14 and 22
increased uptake was observed in hippocampus. 4) there was increased postsynaptic glutamate
binding at PND 2, 14 and 22 in cortex. Moreover, there was reduced binding at PND7 in cortex.
These findings suggest that the cortex and hippocampus are negatively affected by Pb2+
producing increased brain excitability with the cortex alterations proceeding those of the
hippocampus.
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These changes show an increase in spontaneous release of glutamate (i.e. non-specific
signals); which we presume would be the same for any other neurotransmitter; specifically
GABA. These non-specific signals may inappropriately communicate with incorrect targets or
over stimulate to correct targets, thereby altering brain excitability during development in
response to Pb2+. In addition, these Pb2+ induced effects may cause developmental delays
brought forth by imprecise neuronal communication efficiency. The impact of such a
perturbation in early development may manifest in behaviors associated with GABAergic
regulation, impulsivity control, anxiety, habituation, attentional mechanisms and learning and
memory processes.
In order to determine whether or not Pb2+ gestational exposure had caused alterations in
GABAergic mediated behaviors, we subjected animals to a battery of tests for anxiety (i.e. open
field, elevated plus maze, light: dark and hole board), Pavlovian fear learning extinction and
altered context and cued conditioning, and acoustic startle non-associative learning and with prepulse conditioning. The responsivity of the rats were then further evaluated through the
controlled effects of taurine, a GABAergic agonist, given as an i.p. injections of 43mg/Kg 15
minutes before each test with the exception of the context fear (i.e. as taurine has been reported
to reduce nociception in the anterolateral pathway and may attenuate pain sensory inputs which
are used as unconditioned stimuli in classical Pavlovian conditioning).
In the open field, Pb2+ induced fear as evidenced by rats having shorter latencies to
remain in the center zone and engaging in thigmotaxis (i.e. staying by the walls and not moving
into the center area). Interestingly, taurine had reduced anxiety in both controls and Pb 2+ rats by
increasing their latency to move from the wall to remain in the center area longer, while freezing
less in the center.
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In the elevated plus maze, taurine increased locomotor activity in control rats in all zones
and made them more reactive in the open arm; thus reducing their anxiety in this test. In
contrast, Pb2+ rats were not affected by taurine, with the exception of head dips. Taurine reduced
Pb2+ rats time and number of head dips suggesting an anxiogenic, rather than anxiolytic effect.
In the light: dark test, control and Pb2+ rats did not differ from one another in anxiety
profiles. In contrast, taurine increased initial time freezing in the light chamber for both controls
and Pb2+ rats. Notably, the Pb2+ treated rats given taurine froze substantially in the light chamber
for the majority of the test session indicating a anxiogenic effect.
This first set of rats showed preliminary inferences of taurine effects on anxiety based
behaviors. Since the open field showed more positive effects on taurine reducing anxiety, we
decided to use another set of rats in a hold board test which contained a similar arena, with the
exception of 16 1" holes in the center, to assess whether or not we could evaluate Pb2+ induced
effects on freezing behavior absent of any painful aversive stimuli and if we could further
augment the Pb2+ rats behavior with contextual cues (i.e. odorants) to motivate them to move and
explore the test environment. The hole board test showed an ability to assess the effects of zone
within this test (i.e. center vs. outer) similar to the open field, but with greater sensitivity and
abilities to parse taurine effects on rat freezing and exploration behaviors across two days of
testing.
Pb2+ rats showed increased freezing and prolonged latency to make first head poke as a
fear escape response when compared to controls on day 1. Taurine had no effects on escape
latency to first head poke. Interestingly, taurine recovered Pb2+ rats exploration latency on day 2
when compared to Pb2+ rats and were equivocal to controls. Taurine did not produce an effect on
control rats. Pb2+ rats administered taurine also exhibited less time freezing on day 1 and more
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time exploring on day 2 when compared to Pb2+ , control and control and taurine rats. The same
was observed for time spent hole poking. There were no taurine effects on control rats. These
data suggest that Pb2+ rats may respond to differently to contextual environmental cues. The
state of anxiety or distress that the rat undergoes in novel testing situations may be over active in
Pb2+ rats which is why taurine recovers behaviors in the hold board test. In contrast, control rats
experience the same contextual environmental cues, but are unaffected by taurine administration;
suggesting that the Pb2+ rats may have an altered GABAergic system which is more sensitive
than the control rats.
In order to further assess whether Pb2+ rats respond differently to contextual
environmental cues we subjected another set of rats to a classical Pavlovian conditioning
paradigm. This test revealed that Pb2+ rats learning abilities are not different from controls, but
Pb2+ rats are more sensitive to aversive stimuli (i.e. Pb2+ makes them more reactive to stressors)
and they are less inclined to pick up the contextual environmental cues due to this elevate stress
response. The consequence of these Pb2+ induced effects produce diminished memory
consolidation during testing and poor retention during extinction trials 24 hrs later.
In order to better understand context learning and its contribution to fear acquisition and
extinction we tested another set of rats and subjected them to an auditory cued and altered
context test paradigm. These Pb2+ rats exhibited similar problems to the previous groups where
reduced contextual learning was observed and poor retention; whereas, Pb2+ rats exhibited
increased sensitivity to aversive conditions, were more reactive and still produced poor retention.
Notably, Pb2+ rats were able to evince memory from the initial training sessions in an altered
context 48 hrs later when they were presented with the conditioned sound that was paired with
the aversive foot shock. This indicated that the rats were able to recall the sound and its
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associative penalty in another context; therefore auditory processing was intact. However, we
were not certain as to whether or not these animals were hypersensitive to auditory stimuli as
high reactives, similar to the aversive foot shock. This was peculiar since in the initial testing
contextual environment these rats produced poor retention, but in an altered context they froze
more due to the increased reactivity to the sound duration rather than to context memory.
To address this last aspect of auditory sensory contribution/impairment to learning and
memory we subjected rats to the acoustic startle response with pre-pulse inhibition. This test
permits us to evaluate the contribution of the rats auditory sensory pathway and its subsequent
sensori-motor behavior with taurine to determine whether Pb2+ decreased inhibition can be
recovered pharmacologically as a potential therapy for Pb2+ exposure.
We first exposed naive rats to 20 continuous trials of 115dB with varied ITIs and
assessed their ability to habituate without any other associated cues (i.e. non-associative
learning). Results showed that Pb2+ rats were more reactive to the sound stimulus and took
longer to habituate than controls. This confirmed our observation of Pb2+ rats being high
reactives to stressors and this sensitivity could, by virtue alone, reduce learning based on poor
attentional, increased impulsivity due to high reactivity, and neuronal processes due to a
compromised/diminished GABAergic system (i.e. reduced GABAergic inhibition results in
hypersensitivity and increased brain excitation).
We then tested another set of naive rats under a startle pre-post test followed by a prepulse paradigm (i.e. 75dB, 85dB, 95dB, and 105dB presented randomly prior to the startle
115dB) to evaluate inhibitory learning of the startle pulse. The results showed that Pb2+ rats had
minimal inhibition in response to the startle pulse following pre-pulse inhibition. Interestingly,
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taurine had no effect on control rats, but taurine significantly increased inhibition in Pb2+ treated
rats; even more so than controls.
Lastly, we wanted to assess whether or not the GABAAR or the GABAβR was the
contributing target of GABA inhibition or lack thereof in response to Pb2+ treatment. To answer
this question we ran another group of rats and tested them identically, however they were
administered either 3mg/Kg, 6mg/Kg, or 10mg/Kg of Baclofen, a GABAβR agonist, i.p. 15
minutes before testing. The GABAβR showed no differences as an effect of dose in both controls
or Pb2+ treated rats. Moreover, there were no control (+) Baclofen effects when compared to
Pb2+ (+) Baclofen indicating that either the GABAβR system was not involved in regulating prepulse inhibition mediated by this behavioral assay and/or the GABAAR plays more of a critical
role in pre-pulse inhibition then its possible ratio of GABAβRs. In addition, GABABRs can also
activate glycine receptors on the spinal cord and essentially equally reduce all motor activity in
this test thereby making it indiscernible to parse between GABABRs influence in a sensori-motor
task. The selective effects of taurine on recovering the inhibitory learning through the pre-pulse
test is quite convincing that Pb2+ induces stress and hyperactivity due to a reduced GABAergic
system, which can be ameliorated by taurine.
This suggests that taken together taurine, or another GABAAR agonist, may be a potential
exogenous pharmacotherapeutic agent for compensating for Pb2+ induced neurodevelopmental
perturbations and subsequent lifelong effects regarding the following: 1) reduced efficiency of
the GABAergic system, 2) increased reactivity and hypersensitivity to sensory and aversive
stimuli, 3) reduced attentional based mechanisms due to elevated stress responding, 4) difficulty
in habituating to novel environments, 5) and

impaired cognition and memory retention

negatively impacting behavior.
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In conclusions this body of work has identified the following:



Gestational Pb2+ interferes with immature neuronal VSCCs and GABAAR mediated gene
regulation in early development which has never been reported in this framework we
present here.



Specifically, gestational Pb2+ alters the expression pattern of the genes regulating the
GABA-shift in cortex and hippocampus. Brain regions are differentially affected.



Gestational Pb2+ induces developmental delays through altered expression of KCC2
differentially affecting cortex and hippocampus excitation-to-inhibition signaling.



Gestation Pb2+ induces altered neurotransmitter signaling resulting in increased brain
excitability post synaptically.



Gestational Pb2+ disrupts GABAergic regulation of emotional and cognitive behaviors
producing deficits in inhibitory learning and memory which can be recovered by taurine
pharmacotherapy.
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Future studies based on what we report here can be designed in the following ways to
further this body of work:



Investigate the effects of gestational taurine and Pb2+ exposure in potentially ameliorating
Pb2+ induced gene dysfunction in early development.



Assess in primary neuronal cultures taurine and Pb2+ dose responses and their effects on
VSCC-β3, GABAAR-β3, and KCC2 expression.



Characterize the GDP profiles in hippocampus at PND 2, 7, 14, and 22. Then assess dose
dependently how taurine may play a neuroprotective role in regulating Ca2+ homeostasis
under Pb2+ altered gene expression.



Assess seizure susceptibility as a result of increased brain excitability induced by Pb2+
under GABAergic and Glutamatergic pharmacology.



Assess more advanced cognitive behavioral tests to understand Pb2+ induced impulsivity
and reduced inhibitory control and taurine intervention.

101

7.0-Conclusions
Here we evaluated through qRT-PCR, immunohistochemistry of brain slices and primary
cerebellar granule cell neuronal cultures, synaptosomal physiology, and behavioral
pharmacological assays the effects of Pb2+ on GABAergic neural development in the rat model.
Our data suggest that Pb2+ causes disruption of the GABA shift prior to glutamatergic activation.
These disruptions in early brain wiring result in altered brain connections, disrupted
synaptogenesis, and diminished GABAergic inhibition-to-excitation balancing resulting in hyper
excitable, stress sensitive and learning compromised rats. In addition, GABAAR drugs may be of
benefit to investigate as potential neuroprotective target therapies in this experimental model of
Pb2+ toxicity. Notably, other rodent strains and gender differences may not share the same
outcomes identified in our studies. In addition, the timing at which and exposure of Pb2+ may
produce varied effects; however our model was restricted to a 956ppm Pb2+ exposure level that
began gestationally and proceeded throughout life. When such a pharmacotherapeutic
intervention of GABAAR drugs should begin is unclear at this time, but evidence from this body
of work suggest it may be of value. Early intervention would appear best. However, too much
GABAergic activation may present with the same resultant issues identified here as increased
brain excitability throughout life. We would suggest that the best time to intervene may be best
suited during the postnatal day 7-14 plastic 'critical period' (i.e. defined as the period when
astrocyte proliferation, dendrite growth, synapse formation, and spine growth are maximal).
This ‘window’ would permit therapeutic action and possible increase the survival of many
necessary neurons during synaptogenesis increasing the ratio between plasticity-to-pruning. We
suggest that gestational Pb2+ exposure causes a reduced accuracy in the precision of cortical and
hippocampal neuronal pruning which may obscure the early developmental transmitting signals
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while increasing non-specific background activity resulting in inappropriate or improper network
connections that persist throughout the lifespan consistent with cognitive impairments purported
in the vast literature.
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